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ABSTRACT 
Background: Since the 1940’s, coronary heart disease (CHD) has been recognized 
as a major cause of death in the developed countries. Men born in eastern Finland 
were found to have internationally high CHD mortality in the late 1960’s. As a result, 
the “North Karelia Project” was launched, aiming to decrease CHD risk factors 
especially in the high risk areas. Since then, CHD mortality rates have decreased 
significantly in Finland with over two thirds of the decline explained by favourable 
changes in modifiable risk factors. Despite the overall reduction, regional differences 
in the rates are still seen. Although regularly studied, the current regional differences 
in Finland in CHD risk factors and surrogate markers subclinical atherosclerosis are 
thoroughly investigated.  
Aims: This thesis aimed to investigate current and 31-year longitudinal CHD risk 
factors between eastern and western Finns, to examine east-west differences in 
subclinical atherosclerosis measured by carotid intima-media thickness (IMT) and in 
cardiac left ventricular (LV) structure and function, to explore CHD risk factors, 
carotid IMT and left ventricular structure and function between urban and rural Finns, 
and to study the association of migration with CHD risk factors and carotid IMT.  
Participants and methods: This thesis uses data from the Cardiovascular Risk in 
Young Finns Study which is a prospective multicentre cohort launched in 1980. 
CHD risk factors have been measured from the participants repeatedly since the 
baseline study. Carotid IMT was first measured in 2001 from the participants and 
echocardiography was included in 2011, when over 57% of the original study 
population participated in the latest follow-up study at the age of 34–49.  
Results: In 2011 CHD risk factor profile between participants with eastern or 
western baseline origin was essentially similar. However, eastern participants have 
excessive risk in longitudinal risk factor analyses and they have higher carotid IMT, 
LV mass and worse LV diastolic function than western participants. Participants 
with urban baseline origin have lower CHD risk factor levels and LVM compared to 
rural participants. Participants who migrated from east-to-west or rural-to-urban 
have currently lower CHD risk factor levels and carotid IMT compared to 
participants who stayed in east/rural areas, respectively.  
Conclusions: Differences between eastern and western Finns in CHD risk factor 
levels are levelling off but can still be found in carotid IMT, LV mass and diastolic 
function, and in longitudinal CHD risk factor analyses. Urban Finns have lower CHD 
risk factor levels compared to rural Finns. Migration from areas characterised by higher 
CHD risk factor levels is associated with improvements in cardiovascular health.  
KEYWORDS: Atherosclerosis, geographic differences, coronary heart disease, 
carotid intima-media-thickness, left ventricular mass  
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TIIVISTELMÄ 
Tausta: Sepelvaltimotauti on maailman johtavia kuolinsyitä ja siihen alettiin 
kiinnittää huomiota länsimaissa 1940-luvulla. 1960-luvulla tutkijat osoittivat, että 
itäsuomalaisilla miehillä on kansainvälisesti verrattuna korkea sepelvaltimo-
tautikuolleisuus. Tähän reagoitiin aloittamalla Pohjois-Karjala-projekti, joka pyrki 
alentamaan sepelvaltimotaudin riskitekijöitä erityisesti korkeimman riskin alueilla. 
Sepelvaltimotautikuolleisuus laski Suomessa 1972–2012 yli 80 %. Yli kaksi 
kolmasosaa tästä laskusta on selitettävissä muutoksilla riskitekijöissä. Tämänhetki-
siä maantieteellisiä eroja sepelvaltimotaudin riskitekijöissä ja varhaisissa valtimo-
muutoksissa ei täysin tiedetä, vaikka aihetta on Suomessa tutkittu säännöllisesti.  
Tavoitteet: Tämän väitöskirjatutkimuksen tavoitteena oli itä- ja länsisuomalaisten 
välinen vertailu sepelvaltimotaudin riskitekijöissä nykyisin ja 31-vuotisen seurannan aikana. 
Lisäksi työssä tutkittiin itä- ja länsisuomalaisten eroja kaulavaltimon intima-media-kerroksen 
paksuudessa (IMT) sekä sydämen vasemman kammion rakenteessa ja toiminnassa. 
Tutkimuksen kohteena oli myös selvittää kaupungissa ja maaseudulla asuvien eroja 
sepelvaltimotaudin riskitekijöissä ja varhaisissa valtimoiden ja sydämen muutoksissa.  
Aineisto ja menetelmät: Tämän tutkimuksen aineisto on LASERI (Lasten 
Sepelvaltimotaudin Riskitekijät) -tutkimuksesta, joka on vuonna 1980 aloitettu 
prospektiivinen monikeskustutkimus. Sepelvaltimotaudin riskitekijöitä on mitattu 
osallistujilta säännöllisesti, heidän kaulavaltimon IMT on tutkittu ensimmäisen kerran 
vuoden 2001 ja sydämen ultraäänikuvaus toteutettu vuoden 2011 seurantatutkimuksessa.  
Tulokset: Vuonna 2011 sepelvaltimotaudin riskitekijöissä ei itä- ja länsisuoma-
laisten välillä ollut eroja. Itä-Suomessa lapsuudessa asuneilla havaittiin korkeammat 
riskitekijätasot 31 vuoden pitkittäisanalyyseissä ja aikuisuudessa suurempi kaula-
valtimon IMT, sydämen vasemman kammion massa sekä heikompi diastolinen toiminta 
kuin länsisuomalaisilla. Kaupungissa kasvaneilla todettiin alhaisemmat sepel-
valtimotaudin riskitekijätasot ja sydämen vasemman kammion massa kuin maaseudulla 
lapsuutensa asuneilla. Itä-Suomesta Länsi-Suomeen tai kaupungista maaseudulle 
muuttaneilla sepelvaltimotaudin riskitekijätasot ja kaulavaltimon IMT olivat 
alhaisemmat kuin heillä, jotka asuivat jatkuvasti Itä-Suomessa tai maaseudulla.  
Johtopäätökset: Itä- ja länsisuomalaisten väliset erot sepelvaltimotaudin 
riskitekijöissä ovat tasaantumassa. Eroja on yhä nähtävissä riskitekijöiden pitkän 
ajan kertymässä sekä varhaisissa valtimo- ja sydänmuutoksissa. Kaupunkilaisilla on 
matalammat sepelvaltimotaudin riskitekijätasot kuin maaseudulla asuvilla. Mata-
lamman sepelvaltimotaudin riskitekijätason alueelle muuttajilla havaittiin matalam-
mat riskitekijätasot kuin heillä jotka jäivät korkeamman riskin alueelle.  
AVAINSANAT: ateroskleroosi, maantieteelliset erot, sepelvaltimotauti, sisemmän 
kaulavaltimon paksuus, vasemman kammion massa  
 6
Table of Contents 
Abbreviations .................................................................................. 9 
List of Original Publications ......................................................... 10 
1 Introduction ........................................................................... 11 
2 Review of the Literature ....................................................... 13 
 Cardiovascular diseases (CVDs) and coronary heart 
disease (CHD) as an international public health problem 
with special reference to Finland ............................................ 13 
 Geographic differences in CVDs ............................................ 15 
2.2.1 Eastern and western Finland division .......................... 15 
2.2.2 East-west- differences in CHD epidemiology in 
Finland ........................................................................ 16 
2.2.3 Urban-rural differences in CHD and other CVDs in 
Finland and worldwide ................................................. 18 
2.2.4 Migration in Finland and association with CVDs .......... 19 
 Atherosclerosis as an etiologic factor for CVDs ...................... 20 
2.3.1 Development of atherosclerotic lesions ....................... 21 
2.3.2 Risk factors for atherosclerosis and CVDs .................. 21 
2.3.2.1 Serum lipids .................................................. 21 
2.3.2.2 Blood pressure ............................................. 22 
2.3.2.3 Obesity ......................................................... 23 
2.3.2.4 Serum glucose and insulin, diabetes ............ 23 
2.3.2.5 Low-level inflammation ................................. 23 
2.3.2.6 Health behaviours ......................................... 24 
2.3.2.6.1 Diet .............................................. 24 
2.3.2.6.2 Alcohol use .................................. 24 
2.3.2.6.3 Physical activity ............................ 24 
2.3.2.6.4 Smoking ....................................... 25 
2.3.2.7 Socioeconomic status ................................... 25 
 Surrogate markers of CVDs ................................................... 26 
2.4.1 Subclinical markers of atherosclerosis ........................ 26 
2.4.2 Left ventricular mass and function ............................... 26 
3 Aims of the Study .................................................................. 28 
4 Participants and Methods .................................................... 29 
 Cardiovascular Risk in Young Finns Study ............................. 29 
4.1.1 Definition of geographic origin ..................................... 30 
 7 
 Data acquisition in the Young Finns Study ............................. 30 
4.2.1 Physical examination ................................................... 30 
4.2.2 Biochemical analyses .................................................. 31 
4.2.3 Definition of hypertension, metabolic syndrome and 
type 2 diabetes in adulthood ........................................ 31 
4.2.4 Ultrasound imaging of carotid IMT ............................... 32 
4.2.5 Echocardiography ....................................................... 33 
4.2.6 Health behaviours, SES and medication 
questionnaires ............................................................. 34 
 Statistical methods ................................................................. 34 
4.3.1.1 Study I .......................................................... 34 
4.3.1.2 Study II ......................................................... 35 
4.3.1.3 Study III ........................................................ 35 
4.3.1.4 Study IV ........................................................ 35 
5 Results ................................................................................... 37 
 Characteristics of the participants (Study III, Study IV) ........... 37 
 CHD risk factors in 2011 according to eastern/western 
baseline origin (Study III) ........................................................ 39 
 CHD risk factors in 1980–2011 according to 
eastern/western baseline origin (Study III) .............................. 40 
 Carotid IMT in adulthood (2007) according to 
eastern/western baseline origin (Study I) ................................ 42 
 LV mass and diastolic function according to 
eastern/western baseline origin (Study II) ............................... 42 
 Urban-rural differences in CHD risk factors, carotid IMT 
and LVM (Study IV) ................................................................ 45 
 Association of migration with CHD risk factors and carotid 
IMT ......................................................................................... 46 
5.7.1 Details of east-to-west and urban-rural migration 
(Studies I, IV) .............................................................. 46 
5.7.2 East-west migration and CHD risk factors (Study I) ..... 46 
5.7.3 East-west migration and carotid IMT (Study I) ............. 48 
5.7.4 Urban-rural migration and CHD risk factors (Study 
IV) ............................................................................... 49 
5.7.5 Urban-rural migration and carotid IMT (Study IV) ........ 50 
6 Discussion ............................................................................. 51 
 Participants ............................................................................ 51 
 Methods ................................................................................. 51 
 Results ................................................................................... 53 
6.3.1 East-west differences in CHD risk factors at 
baseline (1980), longitudinally 1980-2011 and 
currently (2011) ........................................................... 53 
6.3.2 CHD mortality in relation to east-west differences in 
CHD risk factors .......................................................... 54 
6.3.3 Carotid IMT, LV mass and diastolic function 
according to eastern/western baseline origin ............... 55 
6.3.4 Urban-rural differences in CHD risk factors, carotid 
IMT and LVM ............................................................... 56 
6.3.5 Migration, CHD risk factors and carotid IMT ................ 57 
 8
 Strengths and limitations ........................................................ 59 
 Clinical implications ................................................................ 60 
 Future research directions ...................................................... 61 
7 Summary and Conclusions .................................................. 63 
Acknowledgements ....................................................................... 65 
References ..................................................................................... 67 
Original Publications ..................................................................... 81 
  
 9 
Abbreviations 
ApoA1 apolipoprotein A1 
ApoB apolipoprotein B 
BMI body mass index 
CHD coronary heart disease 
CV  cardiovascular 
CVD cardiovascular disease 
DBP diastolic blood pressure 
HDL high-density lipoprotein  
IMT intima-media thickness 
LDL low-density lipoprotein 
LV  left ventricular  
LVM left ventricular mass 
SD standard deviation 
SE  standard error 
SBP systolic blood pressure 
SES socioeconomic status 
YFS Young Finns Study, Cardiovascular Risk in Young Finns Study 
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1 Introduction 
Since the 1940’s, coronary heart disease (CHD) has been recognized as a major 
cause of death in the developed countries. The Seven Countries Study investigated 
the international CHD mortality in the 1960’s and found high CHD mortality in 
Finland compared to other countries (1), in particular among men born in eastern 
Finland.  
The geographical difference in CHD mortality in Finland, namely excess risk in 
eastern Finns compared with western Finns was considered a consequence of higher 
CHD risk factors, mainly hypercholesterolemia, hypertension, and smoking. To 
tackle the observed east-west difference and overall high CHD mortality in Finland, 
a national program called the North Karelia project was launched in the 1970s aiming 
to affect health behaviour and decrease CHD risk factor levels and morbidity, 
especially in eastern Finland (2).  
Following the launch of North Karelia Project, age-adjusted CHD mortality in 
working-age men decreased by 82% and among working-age women by 84% in 
eastern Finland between 1972 and 2012  (3). The decrease in serum total cholesterol 
in men, and the decrease in systolic blood pressure (SBP) and serum total cholesterol 
in women, explained most of the decline in CHD mortality (3). CHD mortality also 
decreased in western Finland, but not as dramatically as was observed in eastern 
Finland. Currently, both men and women residing in eastern Finland have about 20% 
higher CHD mortality compared to those residing in western Finland (National 
Institute for Health and Welfare; 2016).  
In addition to geographical east-west differences in CHD risk factors and 
mortality in Finland, disparity between urban and rural regions in cardiovascular 
diseases (CVD) risk factors and mortality has been confirmed worldwide (4–6). In 
Finland, elevated serum cholesterol levels and obesity are suggested to be more 
pronounced in elderly citizens living in rural than in urban communities (7). CHD 
mortality differences between urban and rural Finns are currently unknown. 
The Cardiovascular Risk in Young Finns Study (YFS) is a national, longitudinal 
multicentre study of Finnish children and adolescents that was launched in 1980 to 
examine precursors of atherosclerosis (8). Studying the differences in CHD risk 
factors between eastern and western Finland and in urban vs. rural Finland was one 
Lauri Vähämurto 
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of the key purposes since the design of the study. The YFS participants residing in 
eastern Finland in childhood have been shown to have higher childhood total 
cholesterol concentrations (9). As adults eastern participants have been shown to 
have higher blood pressure, total cholesterol (10) as well as higher carotid IMT and 
lower brachial flow-mediated dilatation, both markers of subclinical 
atherosclerosis(11), compared to those residing in western Finland in childhood. 
However, longitudinal differences from childhood to adulthood in CHD risk factors 
between eastern and western have not been investigated. Moreover, current 
differences in carotid IMT, and cardiac left ventricular (LV) structure and function 
between eastern and western Finns are not known. Urban-rural differences in CHD 
risk factors, carotid IMT and LV structure and function are also unknown in Finland 
and have not been extensively explored in other populations either. Moreover, the 
association of east-west migration as well as urban-rural migration with CHD risk 
factors and carotid IMT is unknown. 
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2 Review of the Literature 
 Cardiovascular diseases (CVDs) and coronary 
heart disease (CHD) as an international public 
health problem with special reference to 
Finland  
Since the improvements in hygiene, immunization, infrastructure and introduction 
of antibiotics, the average life expectancy in the western world increased 
significantly in the 19th and early 20th century. Due to changes in lifestyle and 
increased life expectancy, CVDs, including hypertension, CHD, myocardial 
infarction and stroke became a health concern. By the 1940’s, half of the deaths in 
the United States were CVD-related (12). The threat posed by the CVDs caught 
attention in the early 1940’s when the president of the United States, Mr Theodor 
Roosevelt, was diagnosed with hypertension and heart failure, and later in 1945 died 
prematurely of hypertension induced cerebral haemorrhage (13). In 1948, one of the 
first long-term epidemiologic studies investigating the causes of CVDs and 
especially CHD was launched in Framingham, Massachusetts (United States) (13). 
The baseline survey in 1948-1952 included over 5,000 participants aged 28 to 62 
years, 55% of which women. The first major results were presented in 1957 declaring 
hypertension as a risk factor for CHD (14).  
Following the Framingham Heart Study, several large studies on CHD were 
launched. The first multinational study on CHD, the Seven Countries Study, was 
conducted in 1957 (1). The study includes cohorts from the United States, Finland, 
Netherlands, Italy, Yugoslavia, Greece, and Japan with a total of 12,763 male 
participants, 40 to 59 years of age. At the baseline survey, the lowest CHD mortality 
rate was found in Japan and in southern European cohorts whereas the highest rate 
was found in Finland, particularly in eastern Finland (1). In the 15-year follow-up 
study, similar trends were still found (15).  
In 1974,researchers found that age-adjusted CHD mortality in the United States 
had been declining since the 1960’s (16). In 1978, the first Bethesda Conference 
concluded that CHD mortality had started declining in the United States. However, 
the causes behind the decline were somewhat unclear. Beneficial changes in diet, 
smoking habits, and other CHD risk factors, as well as improvements in medical care 
Lauri Vähämurto 
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were all considered as contributors. Following the Bethesda Conference, several 
population-based studies in different countries were started in the 1980’s, including 
the Atherosclerosis Risk in Communities Study (ARIC) (17), the Princeton Study 
(18,19), the Muscatine Study (20), the Bogalusa Heart Study (21) and the YFS (22). 
An international study called the MONICA (monitoring trends and determinants in 
cardiovascular disease) was designed by the World Health Organization to monitor 
CHD mortality and events (23). During the 10-year follow-up of the MONICA 
study, the highest total CHD mortality rate among men was found in eastern Finland 
and among women in Glasgow, United Kingdom, whereas the lowest rates in men 
were found in Beijing, China, and in women in Catalonia, Spain (24).  The greatest 
decline in coronary event rates among men during 10 years was found in North 
Karelia, Finland (1983-1992 in Finnish cohorts).  
After a significant decrease in the CHD mortality in the developed countries in 
the 1970’s, the decline started deceleration in countries such as the United States and 
Australia (25) (26). In eastern Europe countries like Poland and Hungary, CHD 
mortality increased until 1990’s and first then started declining (27). Since the 
collapse of Soviet Union, the age-adjusted CHD mortality rates increased in Russia 
and between 1992-1994 the life expectancy at birth dropped by 6.1 years for men 
and by 3.3 years for women (28,29). 
Overall, CHD mortality rates decreased over 40% from 1980 to 2000 in the 
United States (30). Declining CHD risk factors accounted for approximately 44% of 
this mortality decrease, including reductions in total cholesterol concentration 
(24%), systolic blood pressure (SBP) (20%), smoking prevalence (12%), and 
physical inactivity (5%). The reductions in risk factors were, however, partially 
diluted by increasing body mass index (BMI) and prevalence of diabetes. 
Simultaneously, from 1985-1989 to 2000-2004, the age-specific CHD mortality in 
the European Union fell by a third in men and by over a quarter in women (31). In 
Sweden, the age-specific CHD mortality rates decreased by over 50% from 1986 to 
2002, and 55% of the falling-off in CHD mortality was projected to derive from 
declining CHD risk factor levels (32).  In the Seven Countries study, the 40-year 
results showed that CHD annual conditional risk of death had declined in the United 
States, Finnish, Dutch and Japanese cohorts, moderately increased in Italy and 
exponentially increased in cohorts of Serbia and Greece (33).  
In the developing countries, the epidemic of CVDs, such as CHD, hypertension 
and stroke, has mounted first in the most recent decades. In China, CHD mortality 
among men amplified by 50% between 1984 and 1999. It has been estimated that 
about 75% of this increase has been contributed by the increase in total cholesterol 
concentration (34). A profound report from the Global Burden of Disease study 
concluded that premature morbidity due to CHD and other CVDs increased over the 
past 20 years most rapidly in East, South, and Southeast Asia, and parts of Latin 
Review of the Literature 
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America, although the prevalence is still low in these parts of the world when 
compared to the developed countries (35) (36). According to the same report, the 
probability of premature death (age 30-70) attributable to CVD was the highest for 
men in Eastern Europe and for women in Oceania, and the lowest for both sexes in 
the high-income Asia-Pacific region. Globally, CHD is nowadays the leading cause 
of death (37). The prevalence of CHD and other CVDs is predicted to surge in the 
future in the developing countries (38).  
Finally, the new millennium has witnessed the stagnation of decades-long 
decrease in CHD mortality in the United States. This phenomenon is evident 
especially in the younger population (39) and is largely due to emerging obesity and 
type 2 diabetes. Also, the racial and geographical variation in CHD mortality has 
become an alarming problem (40). A decline in CHD mortality in the developed 
countries is not inevitable in the future. In Finland, however, CHD mortality declined 
continuously between 1972 and 2012 altogether astonishingly 82% (from 643 to 118 
per 100,000) among 35-64-year-old men and 84% (from 114 to 17 per 100,000) 
among 35-64-year-old women (3). According to the latest report from the National 
Institute for Health and Welfare, serum total cholesterol concentration is currently 
decreasing in Finland after a temporary increase between 2007 and 2012 
(41).Increasing obesity among the working-aged and persistent hypertension are 
current obstacles in cardiovascular (CV) health (42).  
 Geographic differences in CVDs 
2.2.1 Eastern and western Finland division 
Finland can be divided into eastern and western parts with different borders 
according to the context (Figure 1). Finland became under the influence of Sweden 
in the 13th century and large parts of the country were under the Swedish monarchy 
until 1809, but recurring wars between Sweden and Russia moved the Swedish-
Russian border within Finland several times. After the Nöteborg Peace Treaty in 
1323, eastern parts of today’s Finland were separated from western parts of Finland 
until the end of 16th century as western parts were part of Sweden and eastern parts 
were part of Russia. Until the 20th century, (south) western Finland was one of the 
most developed region in the country and had closest contact with Sweden. 
Northeastern Finland instead was less developed for centuries and has had close 
contacts to outside world mainly via Russia.  
Lauri Vähämurto 
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Figure 1.  East-west- division in Finland. Continuous line is the anthropological line, dashed line is 
the Nöteborg Peace Treaty borderline, and dotted line is the dialect border line.  
2.2.2 East-west- differences in CHD epidemiology in Finland 
Increased CHD mortality in eastern Finland compared to western Finland was 
recognized before the Second World War (43). Especially eastern men were found 
to have higher CHD and overall mortality than western Finns. In the ground-breaking 
Seven Countries Study, a notorious reputation for having the highest CHD mortality 
was linked especially to eastern Finland (1). This excess of risk was explained by 
higher levels of CHD risk factors; middle-aged men in eastern Finland had higher 
blood pressure, serum total cholesterol levels and prevalence of smoking than those 
in southwestern Finland or in any other area included in the Seven Countries study.  
In order to lower the CHD risk factors levels through dietary and other lifestyle 
changes, a pilot project, the North Karelia project was launched in 1972 (2). Between 
1972 and 1982, age-adjusted CHD mortality rate in Finland fell over 40% (44). In 
the FINRISK study in 1982, eastern men still had a higher total cholesterol 
concentration and SBP, and eastern women higher SBP than the western 
counterparts (45). In the baseline study of YFS in 1980, eastern participants (aged 3-
18 years) had higher total and low-density lipoprotein (LDL) cholesterol 
Review of the Literature 
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concentrations than the western participants. From 1982 to 1987, CHD mortality in 
Finland fell over 50%, of which over half was estimated to be the consequence of a 
decline in CHD risk factor levels (46). During the same time period, CHD event risk 
was found to be 40% higher among men in eastern Finland than in western Finland 
and 40% of this excess of risk could be explained by higher rates of CHD risk factors 
(47). 
In 2001, YFS participants with eastern baseline origin had a higher total and LDL 
cholesterol concentration, and SBP and DBP than those originating from western 
Finland (10). In the FINRISK study in 2007, eastern women had higher total 
cholesterol, SBP and BMI compared to western women whereas among men these 
risk factor levels appeared to be similar (48).  Carotid artery intima-media-thickness 
(IMT) has also been found to be higher in eastern Finns compared to western Finns. 
Researchers have shown that carotid IMT correlates with CHD risk factors (49) (8) 
and associates with future CVD’s (50).  Among Finnish-born twins (men) living in 
Sweden, higher IMT was found in those  originating from eastern Finland compared 
to those originating from western Finland (51). In a previous study of the YFS, 
participants originating from eastern Finland were shown to have higher carotid IMT 
than western participants in 2001 (11). Higher carotid IMT was also found in 
participants with eastern grandparents compared to participants with western 
grandparents, and in participants currently living in eastern Finland compared to 
participants currently living in western Finland. Similarly, flow-mediated dilation of 
brachial artery was lower in participants that originated from eastern Finland 
compared to participants with baseline origin in western Finland.  
In 2012 the difference in CHD mortality between eastern and western Finns was 
less than 20% in both sexes (3). According to the most recent data from the National 
Institute for Health and Welfare, CHD mortality in 2016 among 35-84-year-old 
Finns was 21% higher in eastern men and 19% higher in eastern women than among 
western men/women, respectively (National Institute for Health and Welfare; 2016).  
Besides the traditional risk factors such as blood pressure, serum total cholesterol 
and blood glucose levels and smoking, also other reasons have been suggested to 
explain differences in CHD mortality between eastern and western Finns. Eastern 
Finns are on average shorter than western Finns and it has been suggested that a 10 
cm shorter height associates with a 19% increased CHD risk (52). Therefore, the 
height difference could partly explain the higher CHD risk found among eastern 
Finns. Other studies suggest, however, that there is no evident correlation of height 
and CHD risk (53,54). A Finnish study on socioeconomic status (SES) and CHD 
mortality found between 1959-1974 an excessive CHD mortality in east, especially 
in the group with lowest SES (landless participants) (2,19 times the risk of western 
participants with low SES) (55). Association of higher SES with lower CHD risk 
factor levels has been shown earlier in the YFS population (56).  Higher SES is also 
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associated with lower CHD mortality (57) and CVD prevalence (58). These findings 
suggest that east-west- differences in CHD mortality in Finland could associate with 
east-west differences in SES.  
Genetic differences between eastern and western Finns are relatively large, even 
larger than between some nations in Europe and it has been suggested that Finland 
was settled from two directions (59). Finnish maternal mitochondrial DNA is 
essentially similar to other European populations (60) (61), while paternal DNA 
from Y-chromosome shows two distinct lines; one western European and one 
deriving from east (59) (62). Finnish Y-chromosomes also have less haplotypes (less 
variation) than other European populations. This indicates that Finnish gene 
population has undergone several bottle neck -occasions and genetic drifting.  
Family history of CHD and several genetic markers have been acknowledged to 
associate with CHD risk (63,64). Nevertheless, the role of hereditary factors is 
unclear in the prediction of CHD (65). In Finland, previous studies emphasize the 
role of birthplace or early life environment on CHD risk. In the coronary arteries of 
newborns thicker inner vascular layers were found in eastern Finland compared to 
western newborns (66), which could indicate either for the role of differences in 
genetics or pre-birth conditions between eastern and western Finns. In the Helsinki 
Sudden Death Study, men under 54 years of age residing in the west but born in the 
east had higher risk for sudden cardiac death than western-born men (67). Previous 
studies have shown that the parental history of premature CHD is an independent 
risk factor for myocardial infarction and explains part of the disease’s risk difference 
between eastern and western Finland (68) (63). The differences in genetic factors 
cannot, however, explain the major decrease in CHD mortality difference between 
eastern and western Finland as the genetic differences in a population cannot vanish 
in just decades. Finally, CHD mortality in Sweden is similar or lower than that in 
southwestern Finland (69), while in the Karelian Republic of Russia, CHD mortality 
is similar to or higher than that in eastern Finland (70). However, population of the 
Karelian Republic nowadays originates from many parts of the former Soviet Union. 
The findings of CHD mortality differences on both sides of the borders can support 
both environmental and/or genetic factors in explaining the CHD mortality 
differences between eastern and western Finland.  
2.2.3 Urban-rural differences in CHD and other CVDs in 
Finland and worldwide 
The disparity in CVD mortality and risk factor levels between urban and rural 
regions was first recognized in the United States in the early 1970’s (71). The 
increasing geographic, especially urban-rural, differences in CV health became one 
of the major concerns in the United States in the 2000’s as improvements in overall 
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CV health started slowing down (Gillum et al., 2012). Nowadays urban-rural 
disparities in CV health have been confirmed worldwide. Results from the 
Prospective Urban Rural Study have shown that the rates of major CVDs, namely 
CV-related deaths, nonfatal stroke, myocardial infarction, and heart failure were 
higher in rural areas than in urban communities in middle-income and low-income 
countries even though the CHD risk factor levels, e.g. INTERHEART Risk Score, 
were higher in urban communities than in rural settings (6). However, in high-
income countries no urban-rural differences were observed in the rates of major 
CVDs (6). 
In a recent study in Iceland, CVD mortality and risk factor levels were found to 
be higher in the rural areas than in the urban communities (72). In a Chinese 
population, urban citizens living in Hong Kong and Australia were found to have 
higher carotid IMT’s than Chinese living rural areas (5). These results are, however, 
not directly comparable to a high income Western country such as Finland where 
rural lifestyle has become increasingly sedentary. Finally, earlier results from a 
Finnish study suggest that elevated serum cholesterol levels and obesity are more 
prevalent in elderly citizens living in rural communities compared to individuals 
living in urban areas (7). The urban-rural differences among working-age population 
in CHD risk factor levels, carotid IMT and LV structure and function are unknown 
in Finland and have not been extensively explored in other populations either.  
The themes urban-rural and eastern-western are closely linked in the Finnish 
population. The largest cities in Finland (Helsinki Metropolitan area, Tampere and 
Turku) are considered western according to YFS and previous studies as these areas 
have had close connections to west and especially to Sweden during the history. The 
massive migration since the 1950’s from rural to urban areas can mostly be described 
as migration from east to west, most specifically to the Helsinki Metropolitan area.  
2.2.4 Migration in Finland and association with CVDs 
Migration within and emigration from Finland has been considerable during the last 
100 years. More than one million Finns have moved abroad, of which almost 
500,000 before and over 700,000 after Second World War. The majority of the 
emigration was directed to North America before and to Sweden after the war. The 
emigration was mainly motivated by seeking for better work and higher standards of 
living. After  Since the 1980s, emigration due to the economic reasons has decreased 
noticeably as the Finnish economy has become more robust (73).  
In the Second World War Finland lost most of the Karelian Province to the Soviet 
Union and following 400 000 Finnish Karelians were migrated all over other parts 
of Finland.  Since then, migration within Finland has mostly been driven by 
employment-seeking. At first, migration targeted regional centres where industry 
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needed labour. In the last decades, the migration has shifted towards few cities and 
regions characterized by the presence of universities and mostly located in western 
Finland (74). Between 1970 and 2014, only six provinces in Finland have been net-
winners of the migration and Uusimaa-province with the Helsinki Metropolitan - 
area has gained over two thirds of the surplus. Current migraters in Finland are 
characterized by high education and this has increased the regional differences 
concerning income and employment rate.  
The association of migration with regional and individual health and CV health 
in particular, has not been studied to a large extent in Finland. Studies from other 
countries have examples of migration having either positive or negative association 
with individual’s CV health (75)(76).  
 Atherosclerosis as an etiologic factor for CVDs 
Atherosclerosis is the most common underlying cause of CHD, carotid artery 
disease, and peripheral arterial disease. CVDs with atherosclerotic are the leading 
causes of death in developing and developed countries (37). Although these disease 
manifestations occur in middle age or later in life, the vascular atherosclerosis 
leading to these diseases begins often in early life and remains asymptomatic for 
decades. Young male soldiers were shown to have high prevalence of coronary 
atherosclerotic lesions in the Korean and Vietnam War casualties’ autopsy studies 
(77) (78). Autopsies on 2-39 year olds after premature death have shown an 
association of atherosclerotic changes in coronary arteries and aorta with several 
CHD risk factors, e.g. BMI, SBP, DBP, serum total, LDL and HDL cholesterol, 
serum triglycerides and smoking in the Bogalusa Heart Study (79). Since the 1970s, 
large prospective studies have been launched to study further the pathogenesis of 
atherosclerosis. These studies including the Muscatine Study (20), the YFS (22), the 
Coronary Artery Disease Risk Development in Young Adults (CARDIA)  (80), the 
Childhood Determinants of Adult Health (81) (CDAH), and the Special Turku 
Coronary Risk Factor Intervention Project (82) have shown the influence of 
childhood risk factors and lifestyle in the development of atherosclerosis. For 
instance, these prospective studies have shown an association of elevated blood 
pressure in children and adolescents with post-mortem fatty streaks, increased 
carotid IMT, decreased carotid elasticity and impaired endothelial function (79,83–
87) and the association of childhood cholesterol levels with adult carotid IMT and 
coronary artery calcification (49,83,85,87,88). Currently it is largely recognized that 
progression of atherosclerosis begins in childhood and the risk of subclinical 
atherosclerosis in adulthood is associated with childhood CHD risk factors (89).  
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2.3.1 Development of atherosclerotic lesions 
Atherosclerosis is commonly considered as a state of chronic inflammation (90). The 
accumulation of cholesteryl esters in the sub-endothelial space of artery is thought 
to initiate this progression. A fatty streak is the first visible lesion and is rich of foam 
cells that contain cholesteryl esters (91). Particles containing ApoB, such as very 
low-density lipoprotein, LDL and intermediate-density lipoprotein particles, 
contribute to cholesterol plaques. The retained lipoproteins trigger an inflammatory 
response, which gathers monocytes inside the arterial wall and leads to the formation 
of the atherosclerotic lesions (91). LDL-cholesterol has a major role in plaque 
initiation and progression (92). The development of plaque in the arterial wall is a 
process marked by intimal inflammation, necrosis, fibrosis and calcification (93).  
 
Figure 2.  Development of atherosclerosis. Blocks indicate decades of life. The initial lesions 
contain atherogenic lipoproteins that provoke an increase in macrophages in the arterial 
wall causing adaptative intimal thickening. Later on, fatty streaks can be found. Finally, 
atheromas and fibroatheromas are lesions that potentially produce symptoms. 
2.3.2 Risk factors for atherosclerosis and CVDs 
2.3.2.1 Serum lipids 
LDL particles are the main carriers of cholesterol to peripheral tissues. Accumulation 
of LDL and other ApoB containing particles in the subendothelial matrix is a primary 
event in atherosclerosis (94). LDL is modified by oxidation, glycation, aggregation, 
association with proteoglycans, or incorporation to immune complexes. These 
modified LDL particles cause severe injury to the endothelium and underlying 
smooth muscle (95). Raised levels of circulating LDL lead to greater accumulation 
in the arterial wall.  
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LDL-cholesterol levels correlate with atherosclerosis risk and treatments that 
lower LDL- cholesterol decrease CVD morbidity and mortality (96). Familial 
hypercholesterolemia with significantly elevated LDL-cholesterol concentration is 
the most severe human model of atherosclerosis. Elevated LDL-cholesterol 
associates with increased risk of myocardial infarction and vascular death in 
epidemiological studies (97). A 1 mmol/l lower lifetime LDL-cholesterol 
concentration has been estimated to associate with a 54% reduction in CHD 
morbidity(92) .  
HDL particles are a heterogeneous group of molecules characterized by high 
density and smaller size than other lipoproteins (98). Their one hypothesized 
function is to transport cholesterol from peripheral cells to the liver for excretion into 
bile (99). The hypothesis has been reinforced by several animal studies (99,100).The 
Framingham Heart Study established the inverse association of HDL-cholesterol and 
CHD (100). In the last decades large prospective studies have found low HDL-
cholesterol to be an independent predictor of myocardial infarction and ischemic 
stroke, also among those already diagnosed with CVD (101,102).  In some of the 
more recent studies, a drug-induced increase in HDL-cholesterol concentrations did 
not convey any reduction in CVD morbidity (103)(104,105) and HDL- cholesterol 
was not associated causally with CHD risk (106). 
Triglycerides are produced and secreted by liver as chylomicrons in a small extent 
but majority of the blood triglycerides are absorbed from the small intestine. 
Lipoproteins carrying triglycerides deliver free fatty acids to tissues to be used as source 
of energy or to be stored in adipose tissue (107). Elevated serum triglyceride 
concentrations indicate elevated concentrations of very low density lipoprotein. These 
very low density lipoproteins are later transformed into LDLs that contribute to foam 
cell and plaque formation (108). Hypertriglyceridemia is often a part of the metabolic 
syndrome comprising low HDL cholesterol and elevated LDL cholesterol 
concentration as well as obesity and insulin resistance, but eminent triglyceride levels 
alone also associate with higher CHD risk (109). In a meta-analysis with data from over 
300,000 individuals, triglyceride concentrations over 2.8 mmol/l and 2.2 mmol/l 
indicate an increased risk of CHD and ischemic stroke, respectively (110). In 
individuals with baseline triglycerides over 2 mmol/l, a 1 mmol/l reduction in 
triglycerides induced by fibrates reduced coronary events by 43% (111,112). Recent 
Mendelian Randomization studies have found a causal association between triglyceride 
concentration and CHD risk with 1.62 odds ratio for unrestricted allele score (113).  
2.3.2.2 Blood pressure 
Hypertension has several mechanisms that induce atherogenesis (114) (115). The 
risk of CHD has been estimated to double with each increment of 20/10 mmHg 
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beginning from 115/75 mmHg (116). Hypertension is characterized by vascular 
remodelling and stiffness, and it results in endothelial dysfunction with activation of 
renin-angiotensin-aldosterone systems (117). Elevated childhood blood pressure has 
been shown to predict higher incidence of fibrous lesions, increased carotid IMT, 
coronary calcification and decreased arterial elasticity (79) (49) (118). An estimated 
24% of adult men (≥18 years of age) and 21% of adult women have elevated BP 
wordlwide (defined as ≥140/90 mm Hg) (119). 
2.3.2.3 Obesity 
Obesity is nowadays a global epidemic and its prevalence and severity are predicted 
to increase. In 2016, more than 1.9 billion adults were overweight (BMI 25-30 
kg/m2), and 650 million were obese (BMI ≥30 kg/m2) comprising 13% of the 
world’s adult population (120). Obesity is associated with numerous comorbidities 
such as type 2 diabetes, atherosclerosis, CHD and cancer. The YFS has contributed 
to this literature particularly by linking childhood obesity to later cardiometabolic 
health outcomes (121–123). Obesity arises from a combination of genetic and 
environmental factors that interact to promote the phenotype(124).  
2.3.2.4 Serum glucose and insulin, diabetes 
Diabetes is a well-recognized risk factor for early CVDs and it is described by 
elevated blood glucose due to unbalanced glucose-insulin-homeostasis (125). 
Slightly elevated levels of blood glucose and insulin can forecast erupting diabetes 
and hence they may be considered as early CVD risk factors (126). Insulin is the key 
stimulator of glucose uptake in cells from the liver and other glycogen storages. In 
type 1 diabetes, hyperglycaemia is caused by insufficient insulin production 
following autoimmune destruction of pancreatic beta cells. Type 2 diabetes is 
preceded by peripheral insulin resistance combined with beta cell exhaustion that 
leads to jeopardized glucose tolerance and hyperglycaemia. Type 2 diabetes often 
occurs with metabolic syndrome and has become an ever-growing international 
epidemic. It leads to estimated two to three times higher CVD risk compared to the 
non-diabetic population, and to a worse survival prognosis for CVD (127,128).   
2.3.2.5 Low-level inflammation 
Atherosclerosis is considered as a form of chronic vascular inflammation that 
happens mostly in the endothelium (129).Especially high-sensitivity C-reactive 
protein is a promising marker for vascular inflammation and together with 
Framingham score it achieves better predictive accuracy for atherosclerosis than 
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Framingham score alone (130).High-sensitivity C-reactive protein has however poor 
specificity for atherosclerosis as it also associates with old age, hypertension and 
diabetes, for instance.  
Low- level inflammation is associated with poor oral health, for instance. Studies 
have shown that poor oral health increases CVD mortality(131). Especially 
appearance of periodontal diseases seems to have an adverse on CV health (132). 
2.3.2.6 Health behaviours 
2.3.2.6.1 Diet 
Diet impacts several components of CVD risk profile, including obesity, blood 
pressure, lipoprotein profile, glucose-insulin homeostasis, hepatic function, cardiac 
function, inflammation and oxidative stress (133,134). Ideal diet for CV health 
comprises energy balance and dietary quality (135). An ideal diet for CV health is 
rich in vegetables and fruits, fish and whole grains and consist only small amount of 
sodium and sugar- sweetened beverages (136).  
2.3.2.6.2 Alcohol use 
Association of alcohol with CV health is debated. Excessive use of alcohol has a 
negative impact on CV health and increases the risk for stroke (137,138). 
Epidemiologic and clinical evidence suggests, however, that moderate consumption 
of alcohol associates with a reduced risk for developing CHD and ischemic stroke 
(139), possibly by means of reducing cardiac responsiveness during mental stress 
(140).  
2.3.2.6.3 Physical activity 
Lack of physical activity and low fitness are known to elevate the risk for CVDs 
(141). Due to its strong association with CVD mortality, low fitness could be 
considered as an established CVD risk factor besides the traditional risk factors, such 
as blood pressure, serum total cholesterol, blood glucose and smoking (142). The 
association of physical activity with increased CVD mortality is evident regardless 
of ethnicity, body weight and traditional CVD risk factors (143,144). Physical 
inactivity is estimated to cause 6% of the CHD morbidity and account for 9% or over 
5 million of the premature deaths worldwide (145). Physical activity is nowadays 
recognized as a fourth type of risk exposure in non-communicable diseases (146). 
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2.3.2.6.4 Smoking 
Cigarette smoking is a major risk factor contributing to premature mortality and 
CVD morbidity internationally (147). Smoking was estimated to cause 6.4 million 
deaths worldwide in 2015 and the second-leading risk factor for attributable 
mortality among both sexes after hypertension(148). 
Exposure to cigarette smoke induces multiple pathological effects on the 
endothelium (149). Smoking also activates the whole coagulation cascade and the 
increases the risk of thrombotic cardiovascular events (150).  
Epidemiologic studies have shown that cigarette smoking increases the incidence 
of CHD and myocardial infarction (151–153). Depending on the study, active 
smokers have been estimated to have 80% increase and those exposed to passive 
smoking 30% increased risk for fatal CHD (154,155) and smoking men a two-three-
fold death-rate-ratio in the middle-age compared to non-smoking men (156) 
2.3.2.7 Socioeconomic status 
The converse association of SES with CDH mortality (157), myocardial infarction 
(158) and CVD/CHD risk factor levels in adulthood (159) and childhood (19) has 
been shown before. Besides the higher CHD morbidity and risk factor levels, lower 
SES is associated with poorer access to treatment of CHD (160). In Finland in the 
1980’s relative risk of CHD was especially high in subjects from eastern Finland 
with low SES even when compared to western peers with low SES (55). Overall and 
CVD  mortality has been earlier found higher in participants with low SES also in 
the FINRISK-study (161). Association of SES with some of CHD risk factors (BMI, 
SBP, triglyceride, glucose and insulin levels, cigarette smoking and physical 
inactivity) and carotid IMT has been shown earlier in the YFS (56). Also the 
association of SES with arterial stiffness (162) and LV mass and diastolic function 
(163) have been shown in the YFS. An association of SES with rural residency is a 
worldwide phenomenon (164,165).  
Mechanisms underlying the association of SES with CHD and other CVDs are 
numerous. For example, overweight in childhood associates with parental SES and 
predicts obesity also in adulthood (166). Diet, for example consumption of fruits and 
vegetables, is associated with  SES (167,168). Low SES associates also with higher 
alcohol consumption in low and middle-income countries (168), and with more 
alcohol-caused problems in high-income countries (169). Lower SES is also 
associated with psychosocial stress. Alcohol intake, smoking and comfort eating are 
common coping methods for psychosocial stress  (166). For instance, dramatic 
overall and CVD mortality increase in the post-Soviet Russia in the 1990’s was 
shown to be linked with psychosocial stress and increased alcohol consumption 
(170). 
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 Surrogate markers of CVDs 
2.4.1 Subclinical markers of atherosclerosis 
Although the atherosclerotic process begins in early life, clinical symptoms and 
events usually take place at the earliest in middle age. Subclinical changes in the 
structure and function of the vessels can be reliably measured noninvasively. 
Established methods include ultrasound-based assessments of carotid IMT (87), 
carotid artery elasticity (171), endothelial function measured by brachial artery flow-
mediated dilation (172), and coronary artery calcification assessed by computed 
tomography (173). In the present thesis, carotid IMT was used to estimate subclinical 
atherosclerosis.  
The reported association between aortic IMT estimated using ultrasonography 
and by light microscopy in using in vitro samples (174) marked the beginning of 
ultrasound arterial IMT measurement as a tool to estimate subclinical 
atherosclerosis. Carotid IMT has become the method of choice due to its size and 
accessible anatomy, and it is nowadays recognized as a subclinical marker of 
atherosclerosis (175). The measurements are taken between the leading edges of the 
lumen-intima and media-adventitia ultrasound interfaces. Increased carotid IMT 
correlates with CVD/CHD risk factors (49) (8), and the grade of coronary artery 
disease (176) as well as predicts future CVDs (50). In a meta-analysis, a 0.1 mm 
increase in carotid IMT was shown to raise the future risk of myocardial 
stroke/infarction? by 15% and the risk of stroke by 18% (177).  
2.4.2 Left ventricular mass and function 
Increased LVM is a predictor of future CVDs (178) (179).  The relation between 
LVM and CVDs rate in the general population (180) was first reported in the 
Framingham Heart Study. Persistent hypertension contributes to elevated left LVM 
due to increased afterload, as shown in several populations (181–183). In the YFS 
study, it has been shown that childhood ideal CV health associates inversely with 
higher LV mass and impaired diastolic function (184). In the Finnish STRIP- study 
(Special Turku Coronary Risk factor Intervention Project), higher BMI was found to 
associate with increased LVM and septal thicknesses in adolescence (185).   
LV ejection fraction associates with LVM. A pathological increase in LVM often 
occurs simultaneously with decreased ejection fraction and for diagnosis of patients 
with heart failure, ejection fraction was earlier a standard parameter in clinical 
practice (186). Ejection fraction has several limitations, however. The estimation of 
ejection fraction is assessed on linear or two-dimensional measurements, it can 
change significantly based on loading conditions and it is only moderately 
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reproducible (172). It is nowadays widely recognized that heart failure often occurs 
with normal ejection fraction and may be categorized as heart failure with preserved, 
mid-range or reduced ejection fraction (188).   
Heart failure with preserved ejection fraction is sometimes referred to as LV 
diastolic dysfunction. It is recognized as a common clinical manifestation with high 
morbidity and mortality (28). Elevated LVM may contribute to the development of 
diastolic dysfunction (189) although normal LVM can also been found in patients 
with impaired diastolic function (190).  
The ratio of transmitral blood flow velocity during the early filling of the LV (E) 
by mitral annular early diastolic velocity towards left atrium (e’), so called E/e’-ratio 
is a well-established non-invasive indicator of increased LV end-diastolic pressure 
(188). E/e’-ratio is considered as an estimate of LV end-diastolic pressure regarding 
diastolic dysfunction (191,192) and the most extensively studied parameter for 
estimation of LV filling pressure (193).  
The use of E/e′ to estimate LV filling pressures is, however, controversial as it 
does not correlate with invasive measurements in various clinical situations (194). 
When assessing the diastolic function of LV in individual patient with E/e’-ratio it 
is important to acknowledge the subject’s age, possibly underlying CVD and other 
abnormalities found in the echocardiography (195). At a population level,  E/e′ has 
been shown to predict all-cause and CVD mortality and heart failure hospitalizations 
in several disease states, including acute myocardial infarction, cardiomyopathy, and 
heart failure with preserved and reduced ejection fraction (194,196,197). In addition 
to E/e’-ratio, LV diastolic function is related to LV end-diastolic volume (198) and 
E/A-ratio (188). E/A is calculated as dividing transmitral blood flow velocity in the 
early filling of the LV by the transmitral blood flow velocity in the late filling of the 
LV.  
 
 28
3 Aims of the Study 
This thesis aims to study the association of geographic origin with CHD risk factor 
profile, carotid IMT, and LV structure and function in the Young Finns Study. In 
specific, it aims to:  
1. Report the CHD risk factor differences between the eastern and western 
participants in adulthood (2011) and during the 31-year follow-up 
2. Investigate differences in carotid IMT and LV mass and function between 
eastern and western participants in adulthood  
3. Explore the CHD risk factor, carotid IMT and LVM differences between 
urban and rural Finns in adulthood (2007, 2011) 
4. Study the association of migration with CHD risk factors and carotid IMT 
in adulthood (2007, 2011) 
 
Figure 3. Aims of the thesis. Arrows indicate, which associations were studied in this thesis.  
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4 Participants and Methods 
 Cardiovascular Risk in Young Finns Study 
YFS is an ongoing multicentre follow-up study to investigate atherosclerotic risk 
factors from early childhood to adulthood  (199) (8). The study areas are five 
university hospital cities (Helsinki, Turku, Tampere, Kuopio and Oulu) with their 
rural surroundings. Kuopio had a double size sample to able assessment of equal 
number of participants from east and west. The participants were randomly chosen 
from the national register in order to produce a representative sample of Finnish 
children and adolescents. Two pilot studies were conducted in 1978 and 1979. The 
main study was launched in 1980 including 3596 participants aged 3,6,9,12,15 and 
18 years. The follow-up studies have mainly been performed at 3-year intervals. The 
27-year follow-up in 2007 comprised of 2204 subjects and the latest follow-up in 
2011-12 of 2063 participants. The design of YFS and participation rates in the 
follow-ups are shown in Figure 4. YFS has been approved by the Joint Commission 
on Ethics of the Turku University and the Turku University Central Hospital and has 
been conducted according to the guidelines of the Declaration of Helsinki. Informed 
consent was obtained from all participants or their parents. 
 
Figure 4. The design and follow-ups of the YFS  
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4.1.1 Definition of geographic origin 
Participants of this Caucasian population were compared according to their baseline 
origin (1980), current residency (2011) or family origin. Participants were 
determined according to their study centre either as eastern (Kuopio and Oulu) or 
western (Helsinki, Turku and Tampere) (11). Geographically more correct terms 
would be north-eastern and southwestern Finns, but the terms eastern and western 
are commonly used due to historical and simplicity reasons. Family origin was 
assessed by the subjects’ grandparents’ place of birth and was considered eastern if 
all four grandparents were born in eastern Finland (37%) and western if three or four 
grandparents were born in western Finland (20%). Data of grandparents’ birthplace 
was incomplete in 26% of subjects and they were excluded from family origin 
categorization. Proportions of men and women were similar between groups with 
eastern (48,7 % men) and western (49,4% men) baseline origin. 
The living area of participants was also classified as urban or rural. At baseline, the 
participants living in the university cities (Helsinki, Turku, Tampere, Kuopio and Oulu) 
were classified as having an urban place of residence, and the municipalities in the 
vicinity of those cities were classified as rural (Nurmijärvi, Vihti, Loimaa, Mynämäki, 
Orivesi, Ruovesi, Ilomantsi, Juuka, Lapinlahti, Nilsiä, Haapavesi, Pudasjärvi). In 
adulthood, the area of residence was defined on the basis of a question on the subject's 
current place of residence. Participants living in cities, suburbs or center of a 
town/village were classified as having an urban place of residence and participants 
living outside a population center were classified as having a rural place of residence.  
 Data acquisition in the Young Finns Study 
4.2.1 Physical examination 
Weight was measured with weighing scales to the nearest 0.1 kg and height with 
statiometer to the nearest centimetre. BMI was calculated as weight(kg)/height(m)². 
Waist circumference was measured using an anthropometric tape at the midpoint 
between the iliac crest and the lowest rib to the nearest 0.1 cm. The average of two 
measurements was used. Blood pressure was measured from the right brachial artery 
with a standard mercury sphygmomanometer in 1980 and 1983, and with a random-zero 
sphygmomanometer (Hawksley & Sons Ltd, Lancin, UK) in 1986, 2001, 2007 and 2011. 
The measurement was done in a sitting position after a 5-minute rest. The Korotkoff first 
phase was used as the sign SBP, DBP was determined from the fifth phase. Readings 
were performed to the nearest two of millimeters of mercury 3 times on each participant 
and the average of 3 measurements was used in the analysis. From participants 3 years 
old at baseline, only SBP was collected by using an ultrasound device. 
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4.2.2 Biochemical analyses 
In 1980, 1983 and 1986, venous blood samples were drawn after a 12-hour fast and 
stored at -20°C until thawed for the first time for the analyses. In 1980, triglyceride 
concentrations were measured using a fully enzymatic CHOD-PAP method 
(Boehringer Mannheim, Mannheim, Germany) with OLLI 3000 and Kone CD 
analyzers (Kone Co., Espoo, Finland) and determined by using a fully enzymatic 
method (Boehringer Mannheim). Serum HDL-cholesterol concentrations were 
measured from the supernatant after precipitation of very low density lipoprotein 
cholesterol and LDL-cholesterol with dextran sulphate 500 000 (Pharmacia, 
Uppsala, Sweden) (200) in 1980. The concentration of LDL-cholesterol was 
calculated using the Friedewald formula (201). 
From 2001 onwards, venous blood samples were drawn after an overnight fast 
and serum was separated, aliquoted and stored at -70°C until analysis. The assays 
were performed on an AU400 instrument (Olympus, Japan) and the same methods 
were used both in 2007 and 2011. Triglyceride concentration was determined using 
the enzymatic glycerol kinase–glycerol phosphate oxidase method (Triglyceride 
reagent, Beckman Coulter Biomedical, Ireland). Total cholesterol levels were 
measured by the enzymatic cholesterol esterase–cholesterol oxidase method 
(Cholesterol reagent, Beckman Coulter Biomedical). The same reagent was used for 
estimating HDL-cholesterol levels after precipitation of LDL- cholesterol with 
dextran sulfate- Mg2+ (200). LDL-cholesterol was calculated by the Friedewald 
formula in participants with triglyceride levels <4.0 mmol/L (201). The analysis 
methods for total cholesterol and triglycerides have been accredited by the Finnish 
Accreditation Service according to standard ISO/IEC17025.  
Serum glucose concentration was determined with the enzymatic hexokinase 
method (Glucose reagent, Beckman Coulter Biomedical). Due to changes in methods 
or reagents from 2001 to 2007, glucose levels were corrected by using the following 
correction factor equation: Glucose = [glucose (year 2007) – 0.0235]/0.9471. The 
concentration of HbA1c was assayed with an immunoturbidimetric method 
(Hemoglobin A1c assay, Abbott, USA) on an Architect ci8200 analyzer (Abbott) in 
2011. 
4.2.3 Definition of hypertension, metabolic syndrome and 
type 2 diabetes in adulthood 
Hypertension was defined as blood pressure at or above 140/90 mmHg, use of 
reimbursed antihypertensive medication, or the self-reported use of antihypertensive 
medication (202). The metabolic syndrome was defined according to the 
Harmonized criteria (203). The definition included the following criteria; waist 
circumference ≥102 cm in men and ≥88 cm in women, serum fasting glucose ≥5.6 
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mmol/L) or treatment, hypertriglyceridemia ≥1.7 mmol/L) and HDL-cholesterol 
≤1.0 mmol/L) in men and ≤1.3 in women and SBP ≥130mmHg or DBP ≥85 mmHg 
or the use of antihypertensive medication. A diagnosis required that any 3 of the 5 
criteria to be present. Pregnant women were excluded from analyses involving the 
metabolic syndrome (in 2007, n = 37 and in 2011, n = 13). The diagnosis of type 2 
diabetes included participants with fasting serum glucose ≥7 mmol/L) or HbA1c 
≥6.5% or self-reported diabetes or use of medication (204).  
4.2.4 Ultrasound imaging of carotid IMT 
A high-resolution ultrasound system (Sequoia 512, Acuson, CA, USA) with 13.0 
MHz linear array transducer was used to perform carotid ultrasound studies in 2007. 
Ultrasound studies were performed for 2,197 participants in 2007. All studies were 
performed simultaneously by physicians/ultrasound technicians in the five cities of 
the study. Carotid artery IMT was measured approximately 10 mm proximal to the 
bifurcation on the left common carotid artery focusing the image on the posterior 
wall and recording images from the angle showing the greatest distance between the 
lumen-intima interface and the media-adventitia interface. At least four 
measurements were taken at each scan of the common carotid artery incident with 
the R-wave of the continuously monitored ECG to derive mean carotid IMT. One 
reader analysed the scans and was blinded to participants’ details.  
 
Figure 5. Carotid IMT. The layers between the black (media-adventitia interface) and the white 
(lumen-intima interface) arrow represent the intima-media layers in the ultrasound 
image. 
I
MT 
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4.2.5 Echocardiography 
Measurement of LVM and diastolic function with echocardiography was introduced 
to YFS in the latest follow-up in 2011. Echocardiographic measurements and analysis 
were performed according to the European Association of Echocardiography/ 
American Society of Echocardiography guidelines (188,205,206). The sonographers 
in all study locations were trained by a cardiac imaging specialist. Transthoracic 
echocardiography was performed with Acuson Sequoia 512 (Acuson, Mountain View, 
CA, USA) ultrasonography, using 3.5 MHz scanning frequency phased-array 
transducer. Analysis of the echo images was carried out by one observer using 
ComPACS 10.7.8 (MediMatic Solutions, Genova, Italy) analysis program. Both the 
sonographer and the observer were blinded to the subjects’ details.  
LVM was calculated as follows: (0.8[1.04((LV end-diastolic diameter + 
posterior wall thickness + interventricular septum thickness)3–LV end-diastolic 
diameter)3] + 0.6 g (206). LVM was indexed according to subject’s height using the 
allometric power of 2.7 (indexed LVM =LVM/height2.7) since this indexation 
performs better for overweight/obesity (207).  
Continuous and pulse-wave Doppler were used to measure transmitral flow and 
tissue velocities and using this data, LV diastolic performance index, E/e’-ratio, was 
defined as described earlier (205). E wave describes the mitral blood flow during the 
early filling of the LV, and é measures mitral annular early diastolic velocity towards left 
atrium (LA). In this study E/é ratio was calculated using the average of lateral and septal 
values of é velocity. Lower ratio of E/é indicates better LV diastolic function (205).  
 
Figure 6. M-mode ultrasound image obtained during measurement of cardiac LVM. 
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4.2.6 Health behaviours, SES and medication questionnaires 
Self-report questionnaires were used to assess physical activity, smoking, alcohol 
consumption, SES and use of lipid-lowering and antihypertensive medication in 
adulthood. Participants answered the questions themselves, with parents' assistance 
if necessary. The following variables were included in the physical activity 
questionnaire and applied in this study: intensity of physical activity, frequency of 
moderate or vigorous activity, and hours spent on moderate or vigorous activity per 
week (208). Information on cigarette smoking was collected using a questionnaire. 
In childhood, smoking was assessed by a questionnaire in subjects aged ≥12 years. 
Alcohol consumption was determined as standard doses per week. A healthy diet 
score (range 0–27, higher is better) was calculated as a combination of daily 
consumed portions of “healthy” and “unhealthy” foods assessed from a food 
frequency questionnaire (209). In the score, whole grains, fish, fruits, vegetables and 
nuts/seeds are designated as healthy foods, whereas red and processed meats, sweets, 
sugar-sweetened beverages, and fried potatoes were designated as unhealthy. 
 Statistical methods 
Continuous variables are presented as means (±standard deviation, SD or standard 
error, SE) for normally distributed variables or medians (interquartile range) for 
variables with a skewed distribution. Categorical variables are presented as 
proportions. P-values for continuous variables were analysed using independent 
samples t-test when comparing two groups without adjustments. Non-normally 
distributed risk factors were first log-transformed. Categorical risk factors were 
analysed using the chi-square test. Statistical significance was considered as a p-
value <0.05. The analyses were performed with SAS version 9.3 (SAS institute, Inc, 
Cary, NC).   
4.3.1.1 Study I 
In CHD risk factors that showed a significant east–west difference in t-test, an 
analysis of covariance was performed with separate adjustment for age and SES. 
Participants who had moved from east-to-west were compared to the other groups 
for their CHD risk factors in 2007 and 1980 with an age- and sex-adjusted analysis 
of covariance using Dunnett’s multiple comparison correction. Categorical risk 
markers were analysed with a Poisson regression model with a robust error variance. 
P-values were calculated with adjustments for sex, and a further adjustment for age, 
sex, and SES was also made. Sex*east-west migration interactions were studied and 
if significant interactions were found the analyses were done separately for men and 
women. Similar analyses were performed to study the association of east–west 
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migration with IMT. In addition to adjustment for age and sex, the analyses were 
further adjusted for risk factors that showed difference between the groups in 1980 
or 2007.  
4.3.1.2 Study II 
Association of LVM, E/e′-ratio, EF, LV end- diastolic volume and LA end-systolic 
volume with eastern/western baseline origin (also with current residency and family 
origin for LV mass and E/e′) were analysed with an age- and sex-adjusted analysis 
of covariance. Mean, SE and p-values were calculated with adjustment for age, sex 
and area of examination in 2011, and for LVM and E/e′ additionally baseline and 
current CHD risk factors were used as covariates. Birthweight, BMI, SBP, total 
cholesterol, parental SES and physical activity at baseline and BMI, SBP, total 
cholesterol, plasma glucose, prevalence of smoking, own SES and physical activity 
at the time of the echocardiography (2011) were chosen as the covariates since these 
risk factors are known to associate with LVM and we have previously found an east–
west difference in these risk factors in our data.  
4.3.1.3 Study III 
For longitudinal analyses, Z-scores (males and females combined, mean 0, SD 1) 
were generated for continuous risk factor variables; BMI, SBP, DBP, total, LDL- 
and HDL-cholesterol, triglycerides, ApoA1, ApoB, insulin and glucose to 
investigate the east-west differences, but not the secular trends, at each follow-up 
year from 1980 to 2011. The longitudinal differences between participants with 
eastern or western baseline residency were analysed with repeated measures linear 
mixed models. At this point, adjustment was made for age and sex, and the year of 
study using an unstructured covariance structure. As there were no sex*east-west 
baseline residency interactions, data for males and females were analysed together. 
The longitudinal differences in CHD risk factors were further analysed with 
adjustment for parental SES (school years and income status) at baseline as it was 
different between participants with eastern or western baseline residency and is 
known to associate with traditional CHD risk factors. 
4.3.1.4 Study IV 
Continuous variables are presented as means (±standard deviation, SD or standard 
error, SE) for normally distributed variables or as medians (interquartile range) for 
variables with a skewed distribution. Continuous childhood and adulthood variables 
were Z-scored (mean 0, SD 1, standardized for age and sex) for the analyses. 
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Differences in categorical variables were analysed using Fisher’s exact test in 
childhood and logistic regression models adjusted for age and sex in adulthood. The 
association of SES and eastern-western origin with urban-rural differences in CV 
risk factor levels was tested using analysis of covariance adjusted for age, sex, and 
additionally for SES or eastern-western origin. The association of urban-rural 
migration was examined by dividing participants into four groups: 1) participants 
who had lived in rural areas as a child and had migrated to urban communities by 
adulthood (n=587); 2) participants who had continuously lived in urban areas 
(n=991) 3) participants who lived in urban areas as a child and had migrated to rural 
settings by adulthood (n=738); 4) participants who continuously lived in rural 
communities (n=283). Least-square means according to migration classification 
adjusted for age and sex were calculated using analysis of covariance.   
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5 Results 
 Characteristics of the participants (Study III, 
Study IV) 
Clinical and biochemical characteristics of the study population at baseline (1980) 
are presented in Tables 1–2. In this thesis the population was studied for geographic 
differences with special reference to eastern/western differences and urban-rural 
differences, hence we present the baseline characteristic with east-west-division 
(Table 1) and urban-rural-division (Table 2).  
At baseline, participants living in western Finland had significantly lower SBP, 
DBP, total cholesterol, LDL-cholesterol, triglycerides and higher parental SES 
compared with their eastern counterparts (Table 1).  
Those living in urban areas had lower SBP, total cholesterol, LDL-cholesterol, 
triglycerides and higher parental SES compared with rural participants at baseline 
(Table 2).  
Table 1. Baseline (1980) characteristics of the participants with data of CHD risk factors in 
adulthood (2007) according to eastern/western baseline origin. Mean±SD or median 
[interquartile range]* or proportions (%). 
 Eastern Western 
P for difference  Mean ±SD Mean ±SD 
N range  829–961 924–1084 
 
Males (%) 45.2 45.8 0.78 
Age (years) 11.0 ±5.0 10.7 ±5.0 0.20 
Body mass index (kg/m²) 18.0 ±2.9 18.0 ±3.3 0.93 
Systolic blood pressure (mmHg) 114 ±12 112 ±12 <0.0001 
Diastolic blood pressure (mmHg) 70 ±9 67 ±10 <0.0001 
Total cholesterol (mmol/l) 5.36 ±0.98 5.24 ±0.89 0.002 
LDL-cholesterol (mmol/l) 3.49 ±0.91 3.38 ±0.79 0.003 
HDL-cholesterol (mmol/l) 1.56 ±0.30 1.56 ±0.32 0.82 
Triglycerides (mmol/l)  0.68 ±0.32 0.65 ±0.31 0.06 
Insulin (mU/l)* 9.91 [5.90] 9.78 [6.08] 0.61 
Parental SES (school years) 10.6 ±3.7 11.3 ±3.8 <0.0001 
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Table 2. Baseline (1980) characteristics of the participants with data from the 2011, 2007 or 2001 
follow-up in adulthood according to urban/rural baseline origin. mean±SD or median 
[interquartile range]* or proportions (%).  
 Urban Rural 
P for difference  Mean ±SD Mean ±SD 
N range 1192–1394 1244–1509 
 
Males  (%) 46.7 45.2 0.43 
Age (years) 10.7 ±5.0 10.3 ±5.0 0.09 
Body mass index (kg/m²) 17.8 ±3.0 17.8 ±3.2 0.18 
Systolic blood pressure (mmHg) 112 ±12 113 ±12 0.01 
Diastolic blood pressure (mmHg) 69 ±10 68 ±10 0.15 
Total cholesterol (mmol/l) 5.22 ±0.9 5.40 ±0.9 <0.0001 
LDL-cholesterol (mmol/l) 3.36 ±0.8 3.53 ±0.9 <0.0001 
HDL-cholesterol (mmol/l) 1.56 ±0.3 1.56 ±0.3 0.92 
Triglycerides (mmol/l) 0.65 ±0.3 0.68 ±0.3 0.02 
Insulin (mU/l)* 9.60 [5.8] 9.73 [6.1] 0.10 
Parental SES (school years) 11.9 ±3.9 10.2 ±3.4 <0.0001 
Results 
 39 
 CHD risk factors in 2011 according to 
eastern/western baseline origin (Study III) 
Men and women were equally divided in the east-west groups (p=0.78) and the mean 
age between the groups was similar (Table 3). Participants with eastern baseline 
origin were, on average, shorter than those with western baseline origin. There were 
no differences in traditional CHD risk factors in 2011 between participants 
originating from eastern or western Finland. The prevalence of type 2 diabetes and 
hypertension were also similar between participants with eastern/western baseline 
origin. 
Table 3. CHD risk factors in 2011 (mean±SD or median [interquartile range]*) according to 
eastern/western baseline origin. 
 Eastern Western 
P for difference  Mean±SD Mean±SD 
N range 809-961 972-1084  
Males (%) 45.2 45.8 0.78 
Age (years) 42.0±5.0 41.4±5.0 0.94 
Height (cm) 172 ±9 173±9 0.0005 
Body mass index (kg/m²) 26.5 ±4.9 26.6±5.2 0.76 
Waist (cm) 91.4 14.2 92.3±14.2 0.13 
Systolic blood pressure (mmHg) 119±13.4 119±14 0.61 
Diastolic blood pressure (mmHg) 75±10.4 75±11 0.73 
Hypertension (%) 19.9 18.9 0.58 
Total cholesterol (mmol/l) 5.20±0.95 5.17±0.96 0.47 
HDL-cholesterol (mmol/l) 1.32±0.32 1.21±0.31 0.71 
LDL-cholesterol (mmol/l) 3.29±0.83 3.25±0.83 0.29 
ApoA1 (g/l) 1.60±0.24 1.58±0.24 0.27 
ApoB (g/l) 1.06±0.28 1.06±0.29 0.62 
Triglycerides (mmol/l)* 1.05[0.81] 1.05[0.81] 0.87 
Insulin (mU/l)* 7.41[7.05] 7.26]7.20] 0.91 
Glucose (mmol/l)* 5.25[0.63] 5.25[0.74] 0.31 
Metabolic syndrome (%) 20.5 22.4 0.36 
Type 2 diabetes (%) 3.8 4.1 0.73 
Smoking (%) 13.4 12.5 0.16 
Physical activity index (range 5-15)  9.0±1.9 9.0±1.9 0.65 
SES (school years) 15.3±3.4 15.3±3.7 0.74 
Alcohol consumption (doses per week)* 3±5 3±7 0.20 
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 CHD risk factors in 1980–2011 according to 
eastern/western baseline origin (Study III) 
In 1980-2011 BMI was similar between those resident in eastern or western Finland 
at baseline. Eastern participants had significantly higher SBP and DBP from 1980 to 
2011 compared with western participants. As indicated by the 95% confidence 
intervals, eastern participants had higher SBP in 1980, 2001, and 2007 and higher 
DBP in 1980, 1986, 2001 and 2007 compared to western peers. East-west differences 
in SBP and DBP were largest in 2007 but not apparent in 2011. 
Participants with eastern baseline origin had higher total and LDL- cholesterol, 
triglycerides and ApoB concentrations compared with western participants during 
the 31-year-follow-up. At single follow-up years, the concentrations were higher for 
eastern participants in 1980, 1983, and in 1986 only for triglycerides. From 1980 to 
2011, no east-west differences were observed for HDL-cholesterol and ApoA1. At 
single follow-up years, an east-west difference in ApoA1 was found in 1983.  
Participants with baseline origin in east had on average higher glucose but 
similar insulin concentrations compared with those with western baseline residency 
in 1980-2011. At single follow-up years, glucose was higher in 1986 and serum 
insulin in 1983 among the eastern participants.  
The longitudinal analyses investigating differences in CHD risk factors were also 
adjusted for baseline parental SES (school years and income class). Except for 
triglycerides, the observed east-west differences in the risk factors remained 
statistically significant.   
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Figure 7.  ◄▲Longitudinal analyses of coronary heart disease risk factors from 1980 to 2011. N is 
given as number of participants with data from at least one of the follow-ups between 1980 
and 2011. P value is for the longitudinal analyses. Z score is given as mean and 95% 
confidence intervals. * P value <0.05 for east–west difference at a single follow-up year. Y-
axis displays mean Z-score with 95% confidence intervals (eastern, continuous line, N 1726-
1750; western, dash line, N=1808-1842). 1 standard deviation equals 12.2 (1980)–14.1 
(2011) mmHg for systolic blood pressure and 9.6 (1980)–10.5 (2011) mmHg for diastolic 
blood pressure, 0.92 (1980)–0.95 (2011) mmol/l for total cholesterol, 0.83 (1980)–0.83 
(2011) mmol/l for LDL-cholesterol, 0.31 (1980)–0.33 (2011) mmol/l for HDL-cholesterol, 0.22 
(1980)–0.24 (2011) g/l for ApoA1 and 0.18 (1980)–0.29 (2011) g/l for ApoB. 
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 Carotid IMT in adulthood (2007) according to 
eastern/western baseline origin (Study I) 
IMT was higher in participants with eastern baseline origin compared to those with 
western baseline origin. There was no sex*baseline origin interaction indicating that 
the results were similar in both sexes. The IMT difference remained significant after 
adjustment for SES.  
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Figure 8. Carotid IMT in 2007 according to eastern/western baseline origin (mean and 95% 
confidence intervals), adjusted for age and sex. 
 LV mass and diastolic function according to 
eastern/western baseline origin (Study II) 
Participants with eastern baseline origin had greater LVM, indexed LVM and lower 
ejection fraction than subjects with western origin. Concerning LV diastolic 
function, subjects with baseline origin in east had higher E/e’-ratio and LV end-
diastolic volume but no difference in left atrial end-systolic volume or E/A- ratio. 
Table 4. Echocardiography measurements according to eastern/western baseline origin. Mean 
± SE and p-value; adjusted for age, sex and area of examination in 2011. 
   Eastern Western 
P for difference  Mean ± SE Mean ± SE 
N range  902-941 1005-1022  
LV mass, g 139± 1.0 135± 1.0 0.006 
LV mass, indexed, g/m2.7 31.5± 0.2 30.4± 0.2 0.0008 
Ejection fraction, % 58.1± 0.1 58.4± 0.1 0.04 
Left atrium end-systolic volume, ml 43.4± 0.5 44.0± 0.5 0.45 
LV end-diastolic volume, ml 135± 0.9 131± 0.9 0.001 
E/e’- ratio 4.86± 0.03 4.74± 0.03 0.02 
E/A- ratio 1.55± 0.01 1.55±0.01 0.57 
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The mean±SE for LVM in men was 158±33 g and with allometric index 32.5±6.9 
g/m2.7 (N=862). In women, the mean±SE for LVM and indexed LVM were 115±33 g 
and 29.4±6.1 g/m2.7, respectively (N=1045). Indexed LVM according to 
eastern/western baseline origin, current residency and family origin is shown in Figure 
9a (adjusted for age, sex and area of examination in 2011). In all comparisons, the 
eastern participants had higher indexed LVM compared to their western peers. The 
most pronounced east-west difference in LVM was found when the participants were 
studied according their current place of residency. There was no sex*geographic origin 
interaction, indicating that the results were similar for men and women. When the 
analyses were adjusted additionally for CHD risk factors at baseline and currently, the 
east-west differences in indexed LVM persisted (Figure 9b). 
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Figure 9. LV mass (allometric index, mean and SE). a) for participants with baseline origin in east 
(N=902) / west (N=1005), current residency in east (N=653) / west (N=1254), family 
origin in east (N=672) / west (N=401); adjusted for age, sex and area of examination in 
2011. b) for participants with baseline origin in east (N=645) / west (N=745), current 
residency in east (N=465) / west (N=925), family origin in east (N=499) / west (N=309); 
adjusted for age, sex, examination area in 2011, risk factors at baseline (BMI, systolic 
blood pressure, total cholesterol, birthweight, parental SES, physical activity) and 
currently (BMI, systolic blood pressure, total cholesterol, plasma glucose, prevalence of 
smoking, own SES and physical activity)  
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The average E/e’-ratio was 4.6±1.0 in men (N=887) and 5.0±1.0 in women 
(N=1051). The E/e’-ratio according to eastern/western baseline origin, current 
residency or family origin is shown in Figure 10a. The western participants had 
better diastolic function than eastern peers according to baseline origin, current 
residency and family origin. There was no sex*geographic origin interaction 
indicating that the results were similar for men and women. To examine the 
independent association between geographic origin and E/e’-ratio, CHD risk factors 
at baseline and currently were included in the analyses (Figure 10b). When adjusted 
additionally for the CHD risk factors, the east-west difference in E/e’-ratio according 
to family origin was no longer significant but persisted for differences according to 
baseline origin or current residency.  
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Figure 10. E/e’ - ratio (Mean and SE). a) for participants with baseline origin in east (N=920) / west 
(N=1017), current residency in east (N=680)/ west (N=1257), family origin in east 
(N=684) / west (N=407), adjusted for age, sex and area of examination in 2011. b) for 
participants with baseline origin in east (N=655) / west (N=752), current residency in 
east (N=484) / west (N=923), family origin in east (N=505) / west (N=312), adjusted for 
age, sex, examination area in 2011, risk factors at baseline (BMI, SBP, total cholesterol, 
birthweight, parental SES, physical activity) and currently(BMI, SBP, total cholesterol, 
plasma glucose, prevalence of smoking, own SES and physical activity). 
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 Urban-rural differences in CHD risk factors, 
carotid IMT and LVM (Study IV) 
Men and women were equally divided into urban and rural groups (Table 5). 
Participants from urban baseline residency were, on average, older than those with 
rural baseline origin. Urban baseline origin was associated with lower SBP, higher 
alcohol consumption and SES, and a tendency for lower LDL-cholesterol. Carotid 
IMT was similar between the groups but urban baseline origin was associated with 
lower LVM compared to rural baseline origin.  
Table 5. CHD risk factors, carotid IMT and LVM in adulthood according to urban-rural baseline 
origin. Values are expressed as mean ± SD or median [interquartile range]*. Data is 
primarily from the 2011 follow-up (71.5% of the adult data), but in case of missing data 
from 2011, data from 2007 (13.8 of the adult data) or 2001 (14.7% of the adult data) 
were used.   
 Urban Rural 
P for difference  Mean ±SD Mean ±SD 
N range  1004–1394 1395–1509  
Males (%) 46.7 45.2 0.41 
Age (years) 39.9 ±6.2 39.2 ±6.6 0.001 
Body mass index (kg/m²) 26.3 ±4.9 26.4 ±5.1 0.50 
Systolic blood pressure (mmHg) 119 ±14 120 ±15 0.0004 
Diastolic blood pressure (mmHg) 75 ±11 75 ±11 0.98 
Total cholesterol (mmol/l) 5.15 ±1.0 5.18 ±1.0 0.26 
HDL-cholesterol (mmol/l) 1.33 ±0.3 1.32 ±0.3 0.55 
LDL-cholesterol (mmol/l) 3.22 ±0.8 3.27 ±0.8 0.051 
Triglycerides (mmol/l)* 1.05 [0.81] 1.05 [0.71] 0.26 
Insulin (mU/l)* 7.57 [7.21] 7.18 [7.04] 0.41 
Glucose (mmol/l)* 5.25 [0.74] 5.25 [0.63] 0.79 
Metabolic syndrome (%) 21.3  21.5  0.50 
Type 2 diabetes (%) 3.5  3.8  0.65 
Smoking (%) 20.8  20.0  0.55 
Physical activity index (range 5-15) 9.0 ±1.9 8.9 ±1.8 0.33 
SES (school years) 15.4 ±3.6 14.7 ±3.5 <0.0001 
Alcohol consumption (doses per week)* 3.5 [7.0} 3.0 [5.0] 0.0003 
Carotid IMT (in 2007, mm) 0.62 0.09 0.62 0.10 0.56 
LV mass (g/m2.7) 30.42 6.55 31.10 6.66 0.01 
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 Association of migration with CHD risk factors 
and carotid IMT 
5.7.1 Details of east-to-west and urban-rural migration 
(Studies I, IV) 
Most of those who moved east-to-west lived in the Helsinki area in 2007 (n=231, 
79%). Majority (n=223, 77%) of those that moved east-to-west had done so by 2001, 
while 23 (8%) migrated later and 45 (15%) lacked data of place of residence in 2001. 
When analyzing for the association of east-west-migration with rural-urban-
migration, we noticed that 37% of east-to-west migraters also moved from rural to 
urban areas and 43% stayed in urban areas while moving from east-to-west. Thus 
80% of those who migrated from eastern to western Finland lived in urban 
communities in 2011.  
Table 6. Directions of east-to-west-migration and association with urban-rural residency. 
Participants who moved from eastern Finland to western Finland between 1980 and 2007 
(n=291) 
Area of residence in 
1980 Area of residence in 2007 
 Helsinki area Turku area Tampere area Total 
Kuopio area 180 7 29 216 
Oulu area 51 9 15 75 
Total 231 16 44 291 
 Place of residence in 2001 
Eastern Western No data  
23 223 45  
Association with urban/rural residency (N=288) 
 Rural 1980 
Urban 2011 
Urban 1980 
Urban 2011 
Rural 1980 
Rural 2011 
Urban 1980 
Rural 2011 
106 / 37% 124/ 43% 31/ 11% 27/ 9% 
5.7.2 East-west migration and CHD risk factors (Study I) 
In 2007, participants that moved east-to-west between 1980 and 2007 had, on 
average, lower BMI, waist circumference, SBP, DBP, serum insulin and glucose, 
prevalence of hypertension, metabolic syndrome and prevalence of smoking as well 
as higher diet score and SES than participants who lived in east both in 1980 and 
2007 (Table 7). Compared to those who lived in west both 1980 and 2007, 
participants who migrated east-to-west had lower BMI and waist circumference but 
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higher SBP and DBP. The east-to-west-migraters had a higher diet score, SES and 
physical activity than those who continuously lived in west.  
Because of the significant difference in SES between the groups, we made 
further adjustment to the prior analyses for adulthood SES. After the adjustment, 
smoking and physical activity between the groups was similar. Difference in the diet 
score between east-to-west-migraters and those who continuously lived in west also 
became non-significant (data not shown for the analyses adjusted with SES). 
Table 7. CHD risk factors (mean±SD or median [interquartile range]*) in 2007 according to east-
west migration. The probability values show significance compared to the East 1980 
West 2007 group, adjusted for sex and age.  
 
Eastern 
1980 
Western 
2007 
Eastern 
1980 
Eastern 
2007 
P1 
Western 
1980 
Western 
2007 
P2 Mean ±SD Mean ±SD Mean ±SD 
N range 239–291 652–771  952–1106  
Males  (%)  45 45 0.86 46 0.89 
Age (years) 37.6±5.0 37.9±4.9 0.36 37.5±5.1 0.99 
Body mass index (kg/m²) 25.3±4.3 26.2±4.5 0.02 26.1±5.0 0.04 
Waist (cm) 85.7±12.8 88.6±12.8 0.001 89.4±14.0 <0.0001 
Systolic blood pressure (mmHg) 120±15 127±15 <0.0001 118±14 0.02 
Diastolic blood pressure (mmHg) 77±12 80±12 <0.0001 74±12 0.0003 
Total cholesterol (mmol/l) 5.03±0.96 5.09±0.88 0.77 5.02±0.91 1.00 
HDL-cholesterol (mmol/l) 1.36±0.34 1.34±0.32 0.57 1.33±0.33 0.51 
LDL-cholesterol (mmol/l) 3.06±0.85 3.14±0.76 0.49 3.07±0.79 1.00 
ApoA1 (g/l) 1.60±0.26 1.60±0.26 0.94 1.60±0.25 0.97 
ApoB (g/l) 1.01±0.28 1.04±0.26 0.28 1.02±0.27 0.88 
Triglycerides (mmol/l)* 1.05[0.81] 1.15[0.81] 0.67 1.05[ 0.92] 0.84 
Insulin (mU/l)* 6.05[5.87] 7.48[6.30] 0.0007 5.77[5.86] 0.10 
Glucose (mmol/l)* 5.15[0.64] 5.25[0.53] 0.004 5.25[0.63] 0.08 
Metabolic syndrome (%) 13 21 0.01 18 0.08 
Type 2 diabetes (%) 1.7 1.2 0.45 1.7 1.00 
Diet score (range 0-27 ) 14.4±4.0 13.3±4.0 <0.0001 13.6±4.1 0.02 
Smoking (%) 14 21 0.01 18 0.14 
Physical activity index (range 5-
15) 
9.1± 1.7 8.8±1.8 0.08 8.8±1.9 0.01 
SES (school years) 16.6±3.3 15.0±3.3 <0.0001 15.3±3.6 <0.0001 
Alcohol consumption (doses 
per week)* 
3[8] 4[8] 0.17 4[9] 0.99 
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We found a significant sex*east-west-migration interaction in total, HDL- and LDL-
cholesterol, ApoB, triglycerides and insulin suggesting that the associations between 
the groups in these outcomes were different in males and females. Thus, these 
variables were analyzed separately for the sexes (data not shown). In men, these 
variables were found similar between the east-west groups. In women, those who 
moved east-to-west had lower total and LDL-cholesterol, ApoB, triglycerides and 
insulin, and higher HDL-cholesterol concentration than those who stayed in east. 
Compared to women who continuously lived in west, those who moved east-to-west 
had lower insulin and ApoB, and higher HDL-cholesterol. 
5.7.3 East-west migration and carotid IMT (Study I)  
East-to-west-migraters had lower IMT than those who continuously lived in east but the 
IMT was similar to those who continuously lived in west (Figure 11a). The results 
remained similar when the analyses were adjusted for the CHD risk factors that showed 
difference between the groups in 2007 (Figure 11b), and also in 1980 (Figure 11c).  
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Figure 11. Association of east-west migration with carotid IMT (mean and 95% confidence intervals). 
The East1980-West2007 (n=243) group is compared to East1980-East2007 (n=626) and 
West1980-West2007 (n=923) groups. a) Adjusted for age and sex. b) Additionally to a), 
adjusted for risk markers that differed between the groups in 2007. c) Additionally to a), 
adjusted for risk markers that differed between the groups in 1980 and 2007. 
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5.7.4 Urban-rural migration and CHD risk factors (Study IV)  
In 2011 those who had moved from rural surroundings to urban areas between 1980 
and 2011 were younger but had essentially similar CHD risk factor profile than those 
who continuously lived in urban areas. Compared to participants who continuously 
lived in rural areas, rural-to-urban migraters were younger, had lower BMI and waist 
circumference, and higher SES. Compared to those who migrated from urban-to-
rural surroundings between 1980 and 2011, rural-to-urban migraters had lower BMI, 
waist circumference and DBP, lower prevalence of smoking and higher SES.  
Table 8. CHD risk factors (mean±SD or median [interquartile range]*) in 2011. The probability 
values show significance of the difference between the Rural 1980 Urban 2011 group 
and the Urban 1980 Urban 2011 group (P1), Rural 1980 Rural 2011 group (P2) and 
Urban 1980 Rural 2011 group (P3), adjusted for sex and age. 
 
Rural 1980 
Urban2011 
Urban 1980 
Urban 2011 
P1 
Rural 1980 
Rural 2011 
P2 
Urban 1980 
Rural 2011 
P3  Mean ±SD Mean ±SD Mean ±SD Mean ±SD 
N range 406–432 727–775 550–597 223–234 
Men (%)  44.5  46.8  0.34 46.1  0.54 46.3  0.60 
Age (years) 41.0 ±5.2 41.6 ±5.0 0.02 41.7 ±4.9 0.02 41.7 ±4.9 0.06 
Body mass index (kg/m²) 25.9 ±4.8 26.3 ±5.0 0.43 27.1 ±5.4 0.004 27.1 ±4.6 0.007 
Waist (cm) 89.6 ±13.2 91.6 ±14.2 0.06 93.3 ±15.4 0.001 93.0 ±13.0 0.01 
Systolic blood pressure 
(mmHg) 
119 ±14 117 ±14 0.28 121 ±15 0.09 120 ±12 0.77 
Diastolic blood pressure 
(mmHg) 
74 ±11 74 ±10 0.93 75 ±11 0.10 76 ±9 0.03 
Total cholesterol (mmol/l) 5.15 ±0.97 5.17 ±0.97 0.99 5.22 ±0.92 0.57 5.22 ±0.97 0.75 
HDL-cholesterol (mmol/l) 1.34 ±0.35 1.33 ±0.34 0.95 1.31 ±0.32 0.32 1.32 ±0.31 0.88 
LDL-cholesterol (mmol/l) 3.25 ±0.81 3.23 ±0.84 0.96 3.33 ±0.83 0.36 3.31 ±0.85 0.70 
ApoA1 (g/l) 1.60 ±0.25 1.59 ±0.25 0.99 1.58 ±0.22 0.71 1.59 ±0.24 0.99 
ApoB (g/l) 1.04 ±0.28 1.06 ±0.30 0.63 1.07 ±0.28 0.20 1.07 ±0.28 0.51 
Triglycerides (mmol/l)* 0.95 [0.71[ 1.05 [0.81] 0.23 1.05 [0.81] 0.29 1.05 [0.61] 0.51 
Insulin (mU/l)* 6.79 [6.80] 7.41 [7.36] 0.39 7.26 [7.51] 0.28 7.57 [6.41] 0.98 
Glucose (mmol/l)* 5.25 [0.63] 5.25 [0.74] 0.99 5.25 [0.63] 0.77 5.25 [0.74] 0.96 
Metabolic syndrome (%) 18.5  21.1  0.45 24.4  0.06 21.1  0.51 
Type 2 diabetes (%) 3.6  3.7  0.94 4.3  0.64 3.4  0.79 
Smoking (%) 14.4  16.4  0.38 12.5  0.38 20.6  0.04 
Physical activity index 
(range 5-15) 
9.1 ±1.9 9.1 ±2.0 1.00 8.9 ±1.8 0.44 8.9 ±1.8 0.27 
SES (school years) 16.0 ±3.6 15.9 ±3.8 0.95 14.5 ±3.3 <0.0001 14.6 ±3.1 <0.001 
Alcohol consumption 
(drinks per week)*  
3.0 [5.0] 3.5 [7.3] 0.91 2.0 [5.7] 0.35 3.3 [8.0] 0.69 
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5.7.5 Urban-rural migration and carotid IMT (Study IV)  
Participants who had migrated from rural to urban areas by adulthood had 
significantly lower IMT than participants who had migrated from urban to rural areas 
(Figure 12). Participants who had continuously lived in urban areas had significantly 
lower IMT compared to participants who had continuously lived in rural 
communities or who had migrated to rural areas as adults. To examine if the 
association of migration with IMT was mediated by CHD risk factors, the analyses 
were adjusted for risk factor levels at baseline. The results remained similar with the 
exception of lack of difference between participants who had continuously lived in 
urban or rural areas (p=0.42), and the emerged difference (p=0.03) between 
participants who had continuously lived in rural areas and those who had moved to 
rural areas by adulthood. 
      
Figure 12. Carotid IMT (mean) in 2007 in the rural-urban migration.  
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6 Discussion 
 Participants 
This study comprised of participants in YFS which is an on-going epidemiological 
study of CVD risk factors and surrogate markers (Raitakari et al. 2008). Individuals 
aged 3, 6, 9, 12, 15 and 18 years in 1980 were invited (n=4,320) to a cross-sectional 
baseline survey and 3,596 took part (83.2% of those invited). The sampling frame 
was designed to establish a cohort that reliably represented Finnish children and 
adolescents. The participants were equally from both sexes and from urban and rural 
areas. Replies obtained from the non-participating families revealed no systematic 
reason for non-participation. Thus, the final sample in 1980 was concluded to be 
representative of the total random sample (Raitakari et al., 2008).  
Of the original study cohort in 1980, a total of 2,204 individuals (61.3%) 
participated in the 2007 follow-up and 2,063 individuals in the 2011 follow-up 
(57.4%). Non-participation at follow-up is a common limitation in longitudinal 
studies, particularly when non-participation is differential. However, participation of 
this study group in the follow-up studies has been dynamic, with few exceptions. In 
the 1980’s the loss-to-follow-ups were more often men, smokers and older (210) and 
in 2001, loss-to-follow-ups were more often men and younger than follow-ups 
(Juonala et al., 2004). However, there were no differences in men or women between 
participants and loss-to-follow-ups in terms of total cholesterol, blood pressure, BMI 
or physical activity (10).  
To summarise, the sample size of this study had sufficient power for the 
statistical analyses, and the randomly selected study population represented the 
original study population. Hence, the results in this study can be generalized to 
Caucasian populations consisting of apparently healthy individuals. 
 Methods 
Since the methods for laboratory measurements including lipid levels are well 
standardized, the results are reliable. All assays were performed in the Laboratory 
for Population Research of the National Institute for Health and Welfare (Turku, 
Finland) and the following methods of the laboratory are also accredited by the 
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Finnish Accreditation Service according to standard ISO ⁄ IEC17025: total 
cholesterol, HDL cholesterol and triglycerides, glucose. Due to changes in methods 
or reagents between follow-ups, values were adjusted using correction factors 
determined from linear regression analysis using standardized principal component 
adjustments. In addition, lack of systematic changes in the lipid and glucose levels 
during follow-up lend support to the stability of these essential laboratory methods. 
BMI and blood pressure measurements have remained uniform throughout the 
study and therefore can be compared from time-point to time-point, although blood 
pressure differences between study areas should be interpreted with caution (211). 
Self-reported questionnaire measures of physical activity and smoking may 
constitute a potential limitation due to recall or reporting bias. Nevertheless, they are 
widely accepted and affordable instruments for evaluating health behaviours, and 
have been consistently measured through follow-ups. 
For estimating LVM, we used echocardiographic measurement although cardiac 
magnetic resonance has become the gold standard (212). Echocardiographic 
measurement of LVM is based on the assumption that the LV has an ellipsoid shape 
with a symmetric hypertrophic distribution. As linear measures are cubed, even small 
measurement errors have an impact on accuracy. Nonetheless, the echocardiographic 
measurement is still a widely-used method in clinical practice due to its accuracy, 
low cost, good accessibility and fastness (213), especially in large study populations 
(206).   
In our study, echocardiography has been performed only at one time point, thus 
longitudinal estimation of change in cardiac shape cannot be made. To model 
diastolic function, a strain-analysis would have been even more accurate than the 
measurements available in this study (214).  Ejection fraction was calculated from 
measurements made in a single plane. It is also unknown whether any baseline 
differences in LV structure and function existed. Despite the east-west differences 
in LV mass and E/e’-ratio was the majority of our study population well within the 
normal values and thus it is too early to say whether east-west differences in 
prevalence of actual LV hypertrophy and diastolic dysfunction will be seen.  
Echocardiography was performed with same methods and devices but by 
different sonographer in each five centres. This might contribute to the results 
between different areas and thus east-west differences in echocardiographic 
measurements. The echo images were, however, interpreted by the same observer. 
Both the sonographer and the observer were blinded to the subjects’ details. 
Measuring the far wall of the common carotid artery, as done in the YFS, has 
been shown be the most reliable method for assessing carotid IMT (215). Meta-
analyses conclude, however, that common carotid artery IMT alone improves only 
scarcely predictive influence beyond traditional risk factors, whereas including the 
carotid bulb and interior carotid artery IMT improves prediction of both cardiac risk 
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and stroke risk (216). Far wall measurements of the common carotid artery alone 
have been favored in population studies because the common carotid artery is easily 
assessable, reproducible and perpendicular to the ultrasound beam (174,217). 
 Results 
6.3.1 East-west differences in CHD risk factors at baseline 
(1980), longitudinally 1980-2011 and currently (2011) 
The excess CHD mortality among eastern Finns in the 1960s was accompanied by 
higher prevalence of hypertension, smoking and hypercholesterolemia compared 
with individuals from other nations and those from western Finland (1). In the 
nationwide FINRISK-study in 1982, total cholesterol levels among men and SBP 
levels in both men and women in eastern Finland remained higher than among 
men/women from western Finland (Turku/Loimaa). YFS participants (aged 3-18 
years) with baseline eastern origin had higher SBP and DBP, total and LDL-
cholesterol than western participants at baseline in 1980.  
In prior publications of YFS, eastern participants had higher total and LDL-
cholesterol levels at baseline  (1980) (218), and in 2001 higher total cholesterol and 
blood pressure levels (10) than the western participants. In this study, those with 
eastern baseline origin had higher average blood pressure, total and LDL-cholesterol, 
triglycerides, ApoB, and glucose levels than western participants when longitudinal 
data from 1980 to 2011 was applied. Currently (2011) there were no differences in 
traditional CHD risk factors between participants with eastern or western baseline 
origin in this study. Our findings on the longitudinal data indicate that despite similar 
CHD risk factor levels currently in the eastern and western Finns, there remains a 
residual burden or legacy effect of higher CHD risk factors from past decades in the 
east, as has also been suggested earlier (3) (51).  
In the FINRISK-study the regional differences in total cholesterol have been 
constant in both sexes except for men in 2007. The highest levels have been 
measured at each follow-up in one of the eastern areas (North Karelia, Northern Savo 
or Northern Ostrobothnia/Kainuu) and the lowest levels in either one of the western 
areas (Turku/Loimaa or Helsinki/Vantaa) (219). In SBP, regional differences have 
been present in both men and women from 1982 to 2012 with highest levels 
constantly in one of the eastern and lowest levels in one of the western areas. In DBP, 
regional differences have been mostly present since 1982 but continuous and 
systematic east-west difference could not be found. The researchers of the FINRISK-
study have not reported specific east-west-differences of the CHD risk factor levels 
but rather analysed whether there existed any differences between several study 
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areas. Therefore, differences in CHD risk factors between eastern and western Finns 
cannot be exclusively studied in the FINRISK-study.  
The association of health behaviours with the CHD risk factors in relation to the 
observed east-west differences would be a very interesting topic but cannot be fully 
studied in YFS. The FINRISK/FINDIET-study reported the effect of dietary changes 
corresponding to 0.3-0.5 mmol/l change in serum total cholesterol in their study 
between 1982-2012 (220). Analyses for the effect of dietary changes on total 
cholesterol differences specifically between eastern and western Finns have 
nevertheless not been reported. The FINDIET-study (221) also found that salt intake 
among Finns reduced from 13 g/day to 8–9 g/day in men and from11 g/day to 7 g/d 
in women between 1979 and 2007. As YFS participants are representative of the 
Finnish population we suspect that their dietary choices and nutritional intakes are 
in accordance with the FINRISK/FINDIET-studies.  
Currently there were no differences in smoking, physical activity or alcohol 
consumption between participants with eastern or western baseline origin. Earlier 
publications in the YFS study have reported that in 2001 smoking was more frequent 
among participants living in eastern Finland (10), which could associate with their 
higher LDL-cholesterol in longitudinal analyses (222) and increase in their CVD risk 
(147).   
In the last years (from 2011 to 2017) the prevalence of active smoking and serum 
total cholesterol have decreased in the Finnish population according to the FINRISK- 
study. The amount of overweight instead increased in the FINRISK- study from 2011 
to 2017 (42)  
6.3.2 CHD mortality in relation to east-west differences in 
CHD risk factors 
The narrowing of east-west differences in CHD risk factors observed in this study 
has occurred in conjunction with an overall decline in CHD risk factor levels and 
CHD mortality in Finland. In Finland the CHD mortality fell by over 80% among 
working-age men and women from 1972 to 2012 (3). In impact analyses of the 
FINRISK-cohort, the diminishing CHD risk factor levels in the population 
accounted for over 95% of the reduction in CHD mortality in the 1970s (46) and two 
thirds of the CHD mortality reduction from 2002 to 2012. The remaining last third 
of the decline in CHD mortality in the latest decade was due to changes in other 
primary risk factors such as diet and physical activity, and secondary prevention with 
medication and the treatment of acute cardiac events (3).  
In the latest FINRISK-study, the CHD mortality in 35-74 year-old Finns was 
17% lower in western men and 15% lower among western women than in eastern 
Finland (3). According to the National Institute for Health and Welfare’s data from 
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2016, eastern men continued to have 21% higher and eastern women 19% higher 
CHD mortality than western men/women, respectively. The higher CHD mortality 
still found in eastern Finns compared with western Finns supports the legacy effect 
of an earlier, higher risk CHD profile. This kind of legacy effect is known earlier 
from cholesterol-lowering drugs for instance: the WOSCOPS-study found that 
treatment with pravastatin for 5-years reducing CV mortality and hospitalizations 
over a 20-year period (223).  
Finland was settled from two directions (59) and genetic differences between 
eastern and western Finns are larger than between some nations in Europe. It has 
also been suggested (224) that being born in East Finland is a more important CHD 
risk factor than is living there. This might be due to genetics, epigenetics or inherited 
health behaviours. 
Earlier studies have suggested that genetic differences within Finland could 
contribute to the observed east-west difference in CHD risk factor levels (9) and 
CHD risk (47). Twin studies suggested an association of genetics with CHD (51,63) 
(225,226). Family history of CHD (64,227)  and several genetic factors (228) have 
been found to associate with CHD risk. The genetic factors cannot, however, explain 
the remarkable decline in CHD mortality especially in eastern Finland as the 
population has remained seemingly stable within the last decades.  
6.3.3 Carotid IMT, LV mass and diastolic function according 
to eastern/western baseline origin 
Participants with eastern baseline origin had higher adult carotid IMT than 
participants with baseline origin in western Finland, independently of CDH risk 
factors. Higher IMT among participants currently living in eastern Finland compared 
to western participants was also observed in 2001 (11). In a Finnish-based population 
living in Sweden  higher IMT was found in men originating from Eastern Finland 
compared to men originating from western Finland (51).  
Participants with baseline origin or current residency in east Finland also had 
higher LVM and higher E/e’-ratio, indicating subtle differences in diastolic function, 
in 2011 compared to their western peers. These associations were independent of 
childhood and adulthood CHD risk factors. Of note, most of our middle-aged 
population was well within the normal limits for LVM and E/e’. LV hypertrophy 
pathogenesis initiates usually with essential arterial hypertension, reversibly 
reduction in blood pressure is marked with regression of LV hypertrophy (179). As 
the results in this study show, eastern participants have had higher SBP in the 31-
year analyses, which probably contributes to the higher LVM. Nevertheless, LVM 
in east was higher than in west independently of baseline and current risk factors, 
including blood pressure. Higher LVM, E/e’- ratio and carotid IMT support the 
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hypothesis of a persisting increased risk for CVDs in eastern Finns compared to 
western Finns also in the future despite that the risk factor levels are currently 
evening out.  
LV diastolic function is associated to LV end-diastolic volume and E/A-ratio 
besides E/e’- function (198).  In this study, both E/e’ and LV end-diastolic volume 
were higher among subjects with eastern baseline origin compared to western 
subjects, thus indicating less effective diastolic function among eastern Finns. A 
well-established marker of diastolic function, E/A-ratio, showed no east-west 
difference in the study. E/A- ratio typically declines in grade I diastolic dysfunction 
and then increases in more severe stages (194). This narrows its usefulness in study 
populations although it is an excellent tool in the clinical practice when individual 
age and echocardiography are taken into account. Another marker of LV diastolic 
dysfunction, the volume of LA, also remained unchanged in this study. This is 
probably explained by the young age of the study group when considering CVDs. 
The volume change of the LA needs longer exposure time to develop than a change 
in the E/e'-ratio (229,230).  
Eastern family origin, i.e. the number of eastern grandparents, associated with 
higher LV mass and diastolic function, in line with previously reported higher carotid 
IMT and lower brachial flow-mediated dilation in subjects with eastern family origin 
when compared to peers with western family origin (11). The effect of family origin 
might be a result of genetics, inherited health behaviour differences, epigenetics or 
a result of all these. In this study, the subject’s current residency was not controlled 
in the analyses of family origin and may thus affect the association of the family 
origin with LV mass and diastolic function. This study also suggests that migration 
has contributed to east-west differences in LV structure and function as the observed 
differences in LV mass and E/e’ were greater according to current residency than 
according to baseline origin.  
Findings on geographical differences in LV mass and diastolic function are 
limited. Geographic difference in LVM has been found earlier in Germany, where 
north-eastern individuals had higher LVM than south-western individuals (231). A 
systematic review of 33 studies from different countries showed that normal values 
for LVM differ essentially between different nations and ethnicities (232). 
6.3.4 Urban-rural differences in CHD risk factors, carotid IMT 
and LVM  
In childhood, participants of this study living in urban communities had better levels 
in several CHD risk factors than those living in rural areas. Notable was also the 
higher SES among urban children’s parents compared to rural children’s parents. In 
adulthood, the differences had mostly levelled off. In 2011, participants with 
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baseline origin in urban communities had lower SBP than those with baseline origin 
in rural areas, but otherwise the CHD risk profile was similar. The findings are not 
as evident as in the PURE study, a broad study of cardiac risk factors and CVDs 
among adults (n=156,424, mean age 50.7 years) in urban and rural communities on 
five continents, which reported higher INTERHEART Risk Score in rural areas 
compared to urban ones in high income countries (Sweden, Canada, and United Arab 
Emirates) (6). In the PURE-study, no significant urban-rural difference was observed 
for major CVDs. In this study, significant urban-rural differences were shown for 
LVM. The differences were not fully attenuated with adjustment for CHD risk 
factors in childhood and adulthood.  
Prior results from the GOAL cohort study, comprising 2,815 elderly Finnish men 
and women aged 52 to 76 years, showed significant urban-rural differences in serum 
total cholesterol and BMI that could be mainly explained by SES (education) (7). 
Our results are not as pronounced as the GOAL-cohort’s observations. As rural-
urban-migration is associated with improvement in CHD risk profile, the urban-
rural-differences would be more pronounced if we compared participants according 
to their current urban/rural place of residence. In the FINRISK-study, urban-rural 
perspective is not comprehensively studied. Eastern areas in the FINRISK-study can 
be considered also rural whereas western areas as urban (219) even if the study is 
not designed for comparison of urban and rural areas.  
Behavioural and dietary factors may contribute to the differences observed in 
lipids and blood pressure. In the rural communities, fewer healthy dietary choices 
may be available compared to modern urban areas and access to public health care 
can vary. Prior results from a national dietary survey by the National Institute for 
Health and Welfare revealed that rural individuals consume less vegetable and use 
more butter than urban residents on average (233).  
Urban areas of Finland locate nowadays mostly in western Finland whereas 
eastern Finland can be considered mostly rural. The results of the present study 
remained almost unchanged with the adjustment for eastern/western baseline origin, 
however. Hence, the observed urban-rural differences in our study are presumably 
not explained by the eastern/western origin of the participants.  
6.3.5 Migration, CHD risk factors and carotid IMT  
Of those who lived in eastern Finland in 1980, 27% had moved to west by 2007, thus 
migration in our study population has been substantial. Those who moved east-to-
west had lower CHD risk factors than participants who continuously lived in east 
with lower BMI, blood pressure, serum insulin and glucose, for instance. Compared 
to those who lived in west both 1980 and 2007, participants who migrated east-to-
west had no systemically better or worse CHD risk factor profile as their BMI and 
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waist circumference were lower but SBP and DBP higher. In 2001 lower SBP and 
DBP were found among east-to-west migraters compared to those who stayed in east 
in YFS population (10).  
Participants who migrated from east-to-west between 1980 and 2007 had lower 
carotid IMT in 2007 than participants who stayed in east but no difference to those 
who continuously lived in west. The difference in IMT between east-to-west 
migraters and those who stayed in east remained independent of CHD risk factors, 
suggesting that other mediators likely exist. Previously in YFS has been shown that 
carotid IMT increases 0.0057±0.0004 mm/year (234). Applying the vascular age 
concept (235), the IMT difference between participants who moved east-to-west and 
those who stayed in east corresponds to a difference of 4.7 years in vascular age, 
which is even more than the difference between eastern and western Finns (0.0216 
mm corresponding to 3.8 years). The differences in CHD morbidity could not been 
studied because of the young study population. In an earlier study on of middle-aged 
men living in the Helsinki metropolitan area (western Finland), those born in the 
Eastern Finland had higher risk for sudden cardiac death than men born in Western 
Finland (67) 
Participants who had migrated from rural to urban communities by adulthood 
had similar CHD risk factor profile and carotid IMT in adulthood than those who 
continuously lived in urban areas. Rural-to-urban- migraters had instead lower BMI 
and waist circumference than those moved from urban to rural areas between 1980-
2011 and lower BMI, waist circumference, carotid IMT and prevalence of smoking 
than those who continuously lived in rural areas. Migrating from rural-to-urban was 
thus associated with improvements in CV health similarly to east-to-west-migration. 
Improvements seemed to be clearer in east-to-west-migration, however. Earlier 
studies on association of urban-rural migration with subclinical atherosclerosis are 
limited. Urban Chinese living in Hong Kong and Australia were found to have higher 
IMT than Chinese living rural areas (5). These results are, however, not comparable 
to high income Western country such as Finland where rural lifestyle has become 
increasingly sedentary because of mechanization of agricultural work whereas in 
China the risk of atherosclerosis has been traditionally very low in rural areas due to 
environmental factors. 
Participants who moved east-to-west had higher SES than participants 
continuously living in east or west. They also smoked less than those who 
continuously lived in east and were physically more active than those who 
continuously lived in west, but adjustment with SES diluted these differences. This 
suggests that the higher SES among participants who moved east-to-west contributed 
to their healthier CV lifestyle. Participants who moved from rural to urban areas had 
higher SES than participants who continuously lived in rural areas or moved urban-
to-rural and also smoked less than those who moved urban-to-rural. Higher SES 
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among those who moved east-to-west or rural-to-urban likely contributed to better 
health awareness and cardiometabolic risk markers as other studies (157) and YFS 
previous publications have observed (56). This study cannot provide data whether 
migration was a cause or a consequence of higher SES. The data and our knowledge 
on migration in Finland mainly supports that both those who already are highly 
educated and those targeting for high education are prone to move from east to west, 
or from rural to urban areas. 
Similar studies of SES’s association with migration and its influence on CV 
health are not easily found in other populations. In Germany lower CVD mortality 
rates were observed among ethnic Germans who had moved from the former Soviet 
Union to Germany compared to a general German population (236). The researchers 
found higher perceived SES as a possible explanation to this phenomenon.   
Superior CV health in those who migrate from A to B compared to those who 
stay in place A has been earlier found in the Great Britain, where middle-aged men 
who moved from other parts of the country to South Britain had lower CVD 
mortality than men in the rest of the country (75). Controversial results were found 
in Hawaii where men with Japanese ancestry have an excessive CHD risk compared 
with men living in Japan and higher CHD risk factor levels were suggested as an 
explanation (76). Indian Gujaratis living in the Great Britain / United Kingdom were 
also found to have excessive CHD risk factors compared with their Indian 
contemporaries (237).  
 Strengths and limitations 
The prospective study design, follow-up time extending 30 years, detailed 
phenotyping of YFS participants and standardized laboratory methods are the main 
strengths of this study. Of the original 3,596 participants at baseline (1980), over 
57% (2063) participated in the latest follow-up over 30 years later, in 2011. Even if 
CHD and other CVDs are still somewhat rare in the middle-aged population, 
ultrasonography measurements of carotid IMT and echocardiography contribute to 
the clinical implications of the study.  
In longitudinal studies an inevitable limitation is non-participation at follow-up. 
In this study, baseline CHD risk factors were similar among participants and non-
participants, and the study group has been dynamic as discussed previously. 
Therefore, the present study population was likely representative of the original 
population. However, loss to follow-up was greater in cigarette smokers who also 
had higher SBP and DBP in the 2007 and 2011 follow-ups, which might have 
differentially affected secular trend analyses in blood pressure levels and the 
prevalence of smoking and the metabolic syndrome.  
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Diagnosis of type 2 diabetes using fasting glucose and HbA1c should be based 
on repeated measurements to rule out the laboratory error, which was not possible in 
this study. The established diagnostic thresholds for diabetes have been developed 
for plasma glucose (American Diabetes Association 2013) but were determined from 
serum samples in this study. The differences between these two methods are 
minimal, however. Blood pressure was measured using random-zero 
sphygmomanometers which may have resulted in a downward bias in the blood 
pressure levels (Yang et al. 2008). Therefore, the prevalence of hypertension and the 
metabolic syndrome may be lower in this study than in similar studies. Blood 
pressure was measured by a different study nurse in each study center and therefore 
the regional/east-west-differences in blood pressure must be interpreted with caution 
(211). 
Our classification of participants as those who migrated or not (east-to-west, 
west-to-east, rural-to-urban or urban-to-rural) is based on information of their place 
of residence from only a few time points (1980 and 2007 for east-west migration, 
1980 and 2011 for urban-rural migration) and does not consider the possibility that 
some participants may have moved several times between these time-points, nor 
does it consider at which time the migration occurred.  
The methods used to assess diet, e.g. salt intake, have changed during the 30 
years of follow-up, beginning since the participants were children at the baseline. 
Also the questionnaires assessing physical activity habits have been modified during 
the follow-up to capture as well as possible the behaviour in the given age group.  
A further limitation is that questionnaires were used to assess data on lifestyles 
and e.g. consumption of alcohol. Studies have shown that there is a tendency for 
under-reporting of own alcohol consumption in questionnaires (238,239).  
 Clinical implications 
Eastern Finns were shown to have higher CHD mortality and risk factor profile in 
the Seven Countries Study for over 50 years ago (1) The phenomenon has been 
followed ever since and east-west differences in both CHD mortality and risk factor 
levels have been narrowing until nowadays simultaneously with the decline in total 
CHD mortality (3). This study gives support to the diminishing of CHD risk factors 
between Finns originating from eastern or western Finland. Our study highlights the 
success of the North Karelia Project, launched in the 1970’s aiming to improve CV 
health especially in eastern Finland (2), and other health promotion projects in 
Finland.  
However, we found eastern participants having higher burden of CHD risk 
factors than western participants in longitudinal analyses from childhood to 
adulthood. In addition, carotid IMT, LV mass and diastolic function, all surrogate 
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markers of CVDs, were higher among participants with eastern baseline origin. 
These findings propose that we might find a higher prevalence of CVDs in eastern 
Finns still in the future. This motivates why eastern Finns should still be a special 
target in CV health promotion, secondary prevention and regional health care units.  
Due to similar risk factor profile observed today, the excess CHD mortality 
amongst eastern Finns may also vanish in the future. Migration could compromise 
this improvement, however. Over a quarter of baseline’s eastern population had 
moved to western Finland by 2007. These east-to-west migraters had better CHD 
risk profile and higher SES and physical activity than those who stayed in east. 
Higher income, employment rate and SES among east-to-west migraters have also 
been noticed before (74). These findings support the idea that migration from eastern 
to western Finland increases the regional differences in the country.  
Participants with baseline origin in urban communities had a slightly more 
favorable CHD risk factor profile and lower LVM compared to individuals 
originating from rural settings, in line with previous results from Finland (7). It is 
remarkable that urban-rural and eastern/western terms are associated as most urban 
citizens are western in the Finnish population. Rural participants had lower SES than 
their urban peers in this study, which is known to associate with poorer CV and 
overall health. Our findings suggest that, national focus should be targeted on rural 
surroundings and promoting CV health should be emphasized to individuals with 
low SES.  
 Future research directions 
This thesis did not study genetic differences and their possible impact on CHD risk 
profile differences between eastern and western Finns. Several studies from the times 
of Seven Countries Study until the 2010’s have suggested that genetic factors might 
explain the CHD risk factor level differences and mortality differences between east 
and west (240). This thesis supports that the east-west differences in CHD risk 
factors have been more associated with diet and lifestyle than genetics.    
The YFS is a dynamic, on-going study that has followed the participants since 
their childhood. As the study population passes middle-age in the near-future, 
prevalence of CHD and other CVDs increases and possible geographic differences 
become apparent. As the risk profile of the participants has been followed since 
childhood, the role of risk factors and health behaviour in explaining the geographic 
differences of CVDs and the pathophysiology of these diseases should become more 
evident in the future.  
This study reports the CHD risk profile differences between individuals who 
migrated from eastern to western Finland compared to those who stayed in the east. 
These differences and reasons underlying should be studied in other study 
Lauri Vähämurto 
 62
populations also and future follow-ups of the YFS, with special emphasis on 
socioeconomic dispersion. Influence of migration on total east-west-differences 
should also be investigated properly.  
Studies on urban-rural differences in CV health are, although worldwide 
numerous, in Finland only scarce. Socioeconomic disparity seems to contribute to 
these differences and CV health should be studied also in relation to SES. 
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7 Summary and Conclusions 
Firstly, CHD risk factor profile is currently similar between participants with 
eastern/western baseline origin in the Young Finns Study (Study III). In longitudinal 
analyses from 1980 to 2011, participants with eastern baseline origin had higher 
levels in several CHD risk factors, including SBP, total cholesterol and serum 
glucose. These findings support the view that east-west differences in the CHD 
mortality will be seen also in the future but the differences are narrowing.  
Secondly, geographic origin in eastern Finland associated with higher LVM and 
E/e’ (a marker of LV diastolic function) compared with geographic origin in western 
Finland (Study II). Most echocardiographic results of the participants were, 
however, well within the normal limits in these variables. These findings suggest 
that participants with eastern baseline origin might have higher prevalence of LV 
hypertrophy, diastolic dysfunction and other cardiac diseases in the future compared 
to participants with western baseline origin.  
Thirdly, higher carotid IMT was found in eastern participants compared to 
western participants (Study I). Participants who moved from east to west from 1980 
to 2007 had lower carotid IMT, BMI, SBP, serum insulin levels, prevalence of 
metabolic syndrome and higher SES than those who lived continuously in east. The 
study could not explain the causality of migration’s association with improvements 
in CV health.   
Fourthly, participants living in urban areas had a more favorable CHD risk factor 
profile and lower LVM than their rural peers (Study IV). Migration from rural to 
urban areas was associated with improvements in CV health when compared to 
participants who continuously lived in rural areas. Urban-rural differences in CV 
health could offer opportunities for optimizing prevention by targeting subjects in 
areas of the highest need.  
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Figure 13. Conclusions of the study. Refers to the conclusions on the page 61.  
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